US20050261559A1 - Wireless physiological monitoring system - Google Patents
Wireless physiological monitoring system Download PDFInfo
- Publication number
- US20050261559A1 US20050261559A1 US11/130,221 US13022105A US2005261559A1 US 20050261559 A1 US20050261559 A1 US 20050261559A1 US 13022105 A US13022105 A US 13022105A US 2005261559 A1 US2005261559 A1 US 2005261559A1
- Authority
- US
- United States
- Prior art keywords
- wireless
- conductor
- active
- common
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
- A61B5/4041—Evaluating nerves condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0502—Skin piercing electrodes
Definitions
- the invention relates to a wireless physiological monitoring system that can be used to measure a wide variety of physiological signals from a patient for monitoring the patient and/or diagnosing certain medical conditions.
- the measurement of physiological signals from a patient for monitoring the patient and/or diagnosing a particular medical condition conventionally requires medical instrumentation to be physically attached to the patient. This includes attaching electrodes to the patient at the measurement site and then transmitting the measured signals to the medical instrumentation via cables. In some cases, this can result in many cables being connected between the patient and the medical instrumentation. For instance, for multimodality intraoperative monitoring measurements, there may be anywhere from 4 to 32 measurement channels, for electromyography (EMG) measurements there may be 1 to 4 measurement channels, for electrocardiogram (ECG) measurements, there may be ten measurement channels and for measuring brain potentials, there may be more than 128 channels in cases where signals are measured from the cortex.
- EMG electromyography
- ECG electrocardiogram
- the plurality of cables connecting the patient to the medical instrumentation provides many disadvantages.
- the cables are uncomfortable for the patient and limit the mobility of the patient. It is important for the patient to remain mobile so that the patient does not develop any blood clots.
- the cables also make it difficult to perform any tests on the patient which require the patient to move. Further, in some cases, the cables may be stiff and can easily become detached from the patient especially when the patient moves.
- the plurality of cables connecting the patient to the medical instrumentation are also cumbersome for the medical personnel that interact with the patient.
- the entire set-up can be confusing and in some cases requires expertise for arranging all of the different electrodes and cables. Accordingly, the time required for attaching or removing the electrodes and cables to or from the patient can be quite long. This can be detrimental in situations in which speed is of the essence.
- the medical personnel may accidentally trip or become entangled in the cables.
- the cables to the patient are not accessible during surgery since the cables are in the “sterile field”. This is a problem when troubleshooting faulty cables since cables in the operating room are routinely run over by people and heavy equipment and therefore subject to a high failure rate.
- the inventors have developed a wireless physiological monitoring system that includes, at a minimum, at least one wireless sensor and a monitoring device which are linked to one another in a wireless fashion for measuring physiological signals from a patient for monitoring the patient.
- the wireless physiological monitoring system may also be used to perform diagnostic tests on the patient.
- the wireless physiological monitoring system may further include a wireless stimulator that is synchronized with the wireless sensor for performing certain diagnostic tests such as nerve conduction velocity tests, for example.
- the wireless sensor may be a wireless surface electrode assembly. In another instance, the wireless sensor may be a wireless needle assembly. In both cases, the sensors preferably include electrical leads for obtaining active, reference and common voltage measurements. This results in better signal quality for the measured physiological signals since the common mode voltage can be measured and removed from both the measured active and reference voltages.
- the wireless needle assembly is also advantageous in that it requires no external surface electrodes to operate.
- the sensors include a releasably attachable wireless adapter that provides a wireless connection between the sensor and the monitoring device, and a measurement module, for measuring physiological signals from the patient.
- the measurement module is disposable and the wireless adapter may be reused with another measurement module to form another wireless sensor.
- the wireless adapter may communicate according to the Bluetooth communication protocol.
- the wireless adapter includes a processor and a pre-processing stage for processing the measured physiological signals prior to transmitting corresponding wireless signals to the monitoring device.
- the wireless adapter may also include a memory unit for storing the raw measured or processed physiological signals.
- the wireless physiological monitoring system of the invention advantageously allows for faster application and removal of the sensors to a patient since there are no cables that need to be attached.
- the wireless needle assembly When the wireless needle assembly is used as the wireless sensor, the medical practitioner simply places the needle assembly into the recording site and receives high quality signals through the wireless connection without the need to prepare and “wire-up” the patient.
- the wireless physiological monitoring system provides better signal quality for the measured physiological signals since there are no cables which can pick up electromagnetic interference; this is a common problem with conventional equipment. There is also no leakage current once the measured physiological signals have been converted to wireless signals. Furthermore, since all of the components of the wireless physiological monitoring system are totally wireless, the mobility of the patient is not compromised.
- the invention provides a wireless physiological monitoring system for measuring physiological signals from a patient.
- the system comprises a monitoring device having a first transceiver; at least one wireless sensor disposed on a measurement site on the patient for measuring a physiological signal, the at least one wireless sensor having a second transceiver for transmitting a corresponding wireless physiological signal to the first transceiver; and, at least one wireless stimulator having a third transceiver, the at least one wireless stimulator being adapted to provide a stimulation current to the patient in response to at least one of a command signal transmitted by the first transceiver of the monitoring device and manual actuation.
- the at least one wireless sensor includes a wireless adapter having the second transceiver; and, a measurement module having an active conductor and a reference conductor for receiving voltages used to produce a differential voltage measurement indicative of the physiological signal, the measurement module further including a common conductor for receiving another voltage for removing common mode voltage from the differential measurement.
- the second transceiver transmits the differential measurement as the wireless physiological signal.
- a wireless surface electrode assembly is used for the at least one wireless sensor.
- the measurement module of the wireless electrode assembly comprises: a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter; an active electrode for placement on the patient, the active electrode being connected to the active conductor; a reference electrode for placement on the patient, the reference electrode being connected to the reference conductor; and, a common electrode for placement on the patient, the common electrode being connected to the common conductor.
- the active and reference electrodes are located approximately equidistantly from the common electrode.
- a wireless needle assembly is used for the at least one wireless sensor.
- the measurement module of the wireless needle assembly comprises: a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter; and, a shaft which houses the active, reference and common conductors, wherein a first conductor is disposed centrally along the longitudinal axis of the shaft, a second conductor is disposed concentrically about the first conductor, a first insulator is disposed in between the first and second conductors, a third conductor is disposed concentrically about the second conductor, and a second insulator is disposed in between the second and third conductors.
- the invention provides a wireless physiological monitoring system for measuring physiological signals from a patient.
- the system comprises a monitoring device having a first transceiver; and, at least one wireless sensor disposed on a measurement site on the patient for measuring a physiological signal.
- the at least one wireless sensor includes a wireless adapter having a second transceiver; and, a measurement module having an active conductor and a reference conductor for receiving voltages used to produce a differential voltage measurement indicative of the physiological signal, the measurement module further including a common conductor for receiving another voltage for removing common mode voltage from the differential measurement.
- the second transceiver transmits a wireless physiological signal corresponding to the differential voltage measurement to the first transceiver of the monitoring device.
- the system further comprises at least one wireless stimulator having a third transceiver, the at least one wireless stimulator being adapted to provide a stimulation current to the patient in response to at least one of a command signal transmitted by the first transceiver of the monitoring device and manual actuation.
- the invention provides a wireless sensor for measuring a physiological signal from a patient, the wireless sensor being disposed on a measurement site on the patient.
- the wireless sensor comprises: a wireless adapter having a transceiver; and, a measurement module having an active conductor and a reference conductor for receiving voltages used to produce a differential voltage measurement indicative of the physiological signal, the measurement module further including a common conductor for receiving another voltage for removing common mode voltage from the differential measurement.
- the transceiver transmits a wireless physiological signal corresponding to the differential voltage measurement.
- FIG. 1 shows an exemplary embodiment of a wireless physiological monitoring system in accordance with the invention
- FIG. 2 a shows a top view of an exemplary embodiment of a wireless surface electrode assembly for use as a wireless sensor in the system of FIG. 1 in accordance with the invention
- FIGS. 2 b shows an exploded side view of an exemplary embodiment of a wireless surface electrode assembly for use as a wireless sensor in the system of FIG. 1 in accordance with the invention
- FIG. 3 a shows an exploded side view of an exemplary embodiment of a wireless needle assembly for use as a wireless sensor in the system of FIG. 1 in accordance with the invention
- FIG. 3 b shows a magnified view of an exemplary embodiment of the tip of the wireless needle assembly of FIG. 3 a;
- FIG. 4 shows an exemplary embodiment of a wireless adapter for use with either the wireless surface electrode assembly of FIGS. 2 a and 2 b or the wireless needle assembly of FIGS. 3 a and 3 b.
- the wireless physiological monitoring system 10 comprises a monitoring device 12 and at least one wireless sensor 14 .
- the wireless sensors 14 are attached to a patient 16 and each measures a desired physiological signal from the patient 16 .
- physiological signals include an electroencephalographic (EEG) signal, an electrooculographic (EOG) signal, an electromyographic (EMG) signal or an electrocardiographic (ECG) signal.
- EEG electroencephalographic
- EOG electrooculographic
- EMG electromyographic
- ECG electrocardiographic
- the measured physiological signal may be pre-processed by the wireless sensor 14 .
- the wireless sensors 14 then transmit corresponding wireless physiological signals 18 to the monitoring device 12 .
- the transmission frequency may be in the Wireless Medical Telemetry Services (WMTS) band or the Industry Scientific and Medical (ISM) band or any other band approved for this activity.
- WMTS Wireless Medical Telemetry Services
- ISM Industry Scientific and Medical
- the WMTS band includes frequency ranges of 608 to 614 MHz, 1395 to 1400 MHz and 1429 to 1432 MHz.
- the ISM band includes the frequency range of 2.4 to 2.4835 GHz. The structure of the wireless sensor 14 is discussed in more detail below.
- the monitoring device 12 may perform a number of functions on the wireless physiological signals 18 .
- the monitoring device 12 may simply store the wireless physiological signals 18 for later downloading to a computing device which processes the wireless physiological signals 18 .
- the monitoring device 12 may simply be a storage device.
- the monitoring device 12 may itself process the wireless physiological signals 18 as well as possibly display the wireless physiological signals 18 of the processed version.
- the monitoring device 12 may be a suitable computing device such as a laptop computer, a personal computer (PC) or an application specific hardware device.
- the monitoring device 12 comprises a processor 20 , a memory unit 22 , a transceiver 24 with an antenna 26 , a power supply 28 and a display 30 connected as shown in FIG. 1 .
- the processor 20 controls the operation of the monitoring device 12 and initiates monitoring and/or diagnostic tests on the patient 16 via the wireless sensors 14 .
- the processor 20 sends commands via the transceiver 24 to the wireless sensors 14 to initiate monitoring or diagnostic tests and also to synchronize with the wireless sensors 14 .
- the processor 20 may be any suitable processing element, such as a PC central processing unit (CPU) chip, and in some instances may be a digital signal processor (DSP).
- DSP digital signal processor
- the transceiver 24 operates according to a suitable wireless communication protocol.
- the communication protocol may be the Bluetooth communication protocol as discussed in more detail below.
- the processor 20 receives the wireless physiological signals 18 and stores the wireless physiological signals 18 in the memory unit 22 .
- the memory unit 22 may be any suitable memory device such as a hard drive or flash memory or the like.
- the wireless physiological signals 18 can then be downloaded, via the transceiver 24 , or another suitable communications device (not shown), to another computing device for processing.
- the processor 20 may then process the wireless physiological signals 18 according to a processing algorithm that is suitable for the type of monitoring or diagnostic test that is being performed. For instance, noise reduction algorithms may be applied to the signals 18 to improve the signal to noise ratio.
- pattern recognition or other detection algorithms may be applied to the signals 18 to detect certain events in the signals 18 . These noise reduction and pattern recognition algorithms are commonly known to those skilled in the art and will not be discussed further.
- the processor 20 may display the wireless physiological signals 18 or the processed version of the signals 18 on the display unit 30 .
- the display 30 may be a monitor, an LCD, and the like.
- the power supply 28 provides power to the various components of the monitoring device 12 .
- the power supply 28 may be a rechargeable battery or may be a computer power supply unit that is connected to mains power.
- the wireless physiological monitoring system 10 may further comprise at least one wireless stimulator 32 for performing certain diagnostic tests on the patient 16 such as nerve conduction velocity tests.
- the wireless stimulator 32 is used to generate a stimulation current to create an action potential in a nerve of the patient 16 .
- the wireless stimulator 32 includes a stimulation processor 34 , a stimulation generation unit 36 , a stimulation transceiver 38 with an antenna 40 , a stimulation interface 42 , two prongs 44 and a battery 46 connected as shown in FIG. 1 .
- the wireless stimulator 32 may optionally include battery charging circuitry 48 .
- the stimulation processor 34 controls the operation of the wireless stimulator 32 and may be a DSP or a microcontroller.
- the stimulation processor 34 instructs the stimulation generation unit 36 to generate a stimulation current when the stimulation transceiver 38 receives an appropriate command signal from the monitoring device 12 or when it is manually actuated.
- the stimulation generation unit 36 includes circuitry to create the stimulation current having different characteristics depending on the part of the patient 16 to which the stimulation current is being applied.
- the stimulation current is preferably a controlled constant amplitude current and may include a single pulse or multiple pulses where each pulse may be monophasic or biphasic.
- the amplitude may be up to 100 milliamps, the duration of up to 1 millisecond and the maximum voltage is limited to 400 volts.
- the wireless stimulator 32 is applied to the head of the patient 16 , it is used to generate motor-evoked potentials and requires higher amplitude voltages and current. In such an instance, the maximum voltage amplitude is limited to 1000 V, the maximum current amplitude is limited to 1.5 A and the maximum pulse duration is less than 1 ms.
- the stimulation interface 42 allows a medical practitioner to control the wireless stimulator 32 .
- the stimulation interface 42 includes a button, a dial and a small display (all not shown).
- the button may be manually actuated to start and stop the stimulation current, and the dial may be used to change the intensity of the stimulation current.
- the display shows the intensity of the stimulation current and the remaining charge on the battery.
- the wireless stimulator 32 may be controlled from the monitoring device 12 over the wireless link. In both cases, the same level of synchronization is needed between the wireless stimulator 32 and the corresponding wireless sensors 14 that are used to measure the response to the stimulation current.
- the two prongs 44 of the wireless stimulator 32 are applied to a test site on the skin of the patient 16 to stimulate the desired nerve.
- One of the prongs is a cathode terminal and the other prong is an anode terminal.
- the wireless stimulator 32 also has touch-proof adapter connections (not shown) to stimulate through smaller external electrodes or needles for cases in which the prongs 44 are not appropriate.
- the wireless stimulator 32 is powered by the battery 46 .
- the battery 46 is a rechargeable battery. Accordingly, when the wireless stimulator 32 is not in use, the wireless stimulator 32 is placed in a charging stand (not shown) for recharging the battery 46 . In this case, the stimulation processor 34 engages the battery charging circuitry 48 to recharge the battery 46 .
- diagnostic tests in which it is beneficial to have two wireless stimulators.
- One example of such a diagnostic test is a collision study.
- One of the wireless stimulators is used to generate multiple action potentials resulting in a muscle or nerve response from the patient 16 and the other wireless stimulator is used to generate a second action potential in a different nerve that cancels out an undesirable response detected at the recording site.
- the timing between the delivery of the stimulation currents provided by the two wireless stimulators must be controlled to an accuracy of a few hundred microseconds.
- the wireless surface electrode assembly 50 for use as at least one of the wireless sensors 14 in the wireless physiological monitoring system 10 .
- the wireless surface electrode assembly 50 includes a measurement module 52 and a wireless adapter 54 .
- the measurement module 52 includes three conductive electrodes: an active electrode 56 , a reference electrode 58 and a common electrode 60 .
- the three electrodes 56 , 58 and 60 are used so that a differential measurement is made for the desired physiological signal and so that the common mode of the differential measurement can be removed.
- the common electrode 60 is preferably equidistant to both the active and reference electrodes 56 and 58 so that the voltage measured by the common electrode 60 is common to both the active and reference electrodes 56 and 58 .
- the signal provided by the common electrode 60 also allows for removing muscle artifacts from the physiological signals measured by the active and reference electrodes 56 and 58 .
- the electrodes can be made of any biocompatible conductive material with suitable mechanical properties, such as silver-silver chloride, gold, silver, tin, platinum or alloys thereof, or carbon.
- Each of the electrodes 56 , 58 and 60 are wired to a base 62 of the measurement module 52 and are electrically insulated from one another.
- the base may be made of any biocompatible material with suitable mechanical properties, such as Nylon, Teflon or PVC.
- the base 62 further includes three electrical contacts (not shown) on a top portion thereof that interface with corresponding electrical contacts (not shown) on the bottom of the wireless adapter 54 .
- the wireless adapter 54 includes components for transmitting the wireless physiological signal 18 that corresponds to the physiological signal measured by the electrode assembly 50 to the monitoring device 12 . An exemplary implementation of the wireless adapter 54 is described below.
- the wireless adapter 54 has a shape that is complementary to that of the measurement module 52 so that the wireless adapter 54 makes a snap-fit or friction-fit connection with the measurement module 52 .
- the connection is also such that the wireless adapter 54 is releasably attachable to the measurement module 52 . Accordingly, the wireless adapter 54 can be attached to a measurement module 52 , used for physiological monitoring or diagnostic testing on the patient 16 , and then detached from the measurement module 52 once monitoring/testing is completed so that the wireless adapter 54 can be reused and the measurement module 52 can be discarded.
- the wireless surface electrode assembly 50 further includes an adhesive portion preferably applied to a section of each of the electrodes 56 , 58 and 60 to hold the wireless surface electrode assembly 50 in place once the assembly 50 has been attached to the patient 16 .
- an adhesive portion preferably applied to a section of each of the electrodes 56 , 58 and 60 to hold the wireless surface electrode assembly 50 in place once the assembly 50 has been attached to the patient 16 .
- a piece of tape, or other adhesive means may be applied to the electrodes 56 , 58 and 60 of the wireless surface electrode assembly 50 to hold it in place.
- the electrodes may also be glued on with a suitable glue such as collodion.
- the wireless surface electrode assembly 50 may be built into gloves that are worn and held in place by a medical practitioner that is obtaining physiological signals from the patient 16 .
- FIGS. 3 a and 3 b shown therein are an exploded side view, and a magnified view of the tip, respectively, of an exemplary embodiment of a wireless needle assembly 70 , for use as at least one of the wireless sensors 14 in the wireless physiological monitoring system 10 .
- the wireless needle assembly 70 includes a measurement module 72 and the wireless adapter 54 .
- the measurement module 72 includes a shaft with a needle tip 74 disposed at the end; the shaft and needle tip having three concentric conductors: an active conductor 76 , a reference conductor 78 and a common conductor 80 .
- the active and reference conductors 76 and 78 are separated by an insulator 82 .
- the reference and common conductors 78 and 80 are separated by an insulator 84 .
- the three conductors 76 , 78 and 80 are used, in a similar manner to wireless sensor 50 , so that a differential measurement may be made for the desired physiological signal and so that the common mode component of the differential measurement may be removed.
- the common conductor 80 is advantageously in close proximity to both of the active conductor 76 and the reference conductor 78 so that it provides a close approximation to the common mode voltage of the active and reference conductors 76 and 78 .
- the location of the reference, common and active conductors 76 , 78 and 80 are interchangeable.
- the center conductor 76 may instead be the common conductor and the outer electrode 80 may be the active conductor.
- the active and reference conductors 76 and 78 it is preferable for the active and reference conductors 76 and 78 to remain close to one another to eliminate any far field effects in the measured voltages.
- the common conductor 80 is preferably the outer conductor.
- Each of the conductors 76 , 78 and 80 are wired to a base 86 of the measurement module 72 .
- the base 86 further includes three electrical contacts on a top portion thereof that interface with corresponding electrical contacts on the bottom of the wireless adapter 54 .
- the wireless adapter 54 has a shape that is complementary to that of the measurement module 72 so that the wireless adapter 54 is releasably attachable to the measurement module 72 . Accordingly, the wireless adapter 52 is reusable and the measurement module 72 is disposable.
- the entire wireless needle assembly 70 is small enough to facilitate clinical use. Further, the tip 74 of the wireless needle assembly 70 may come in different lengths and diameters to facilitate measurement at muscles or nerves of different sizes and depths. Further details of the needle used by wireless needle assembly 70 are shown and described in co-pending U.S.
- the wireless needle assembly 70 is inserted into a desired measurement site on the patient.
- a piece of tape, or other adhesive means may be applied to the wireless needle assembly 70 .
- the wireless needle assembly 70 may also be held in place by the hand of the medical practitioner who is measuring physiological signals from the patient 16 .
- the wireless needle assembly 70 may not need any tape or adhesive if it is inserted to an adequate depth.
- the tip of the wireless needle assembly 70 may have a hook or corkscrew shape to hold it in place.
- the wireless adapter 54 may be used with other needles having a different number of conductors.
- the wireless adapter 54 may be combined with a measurement module that has a standard monopolar conductor configuration or with a measurement module that has a standard bipolar conductor configuration.
- extra surface electrodes can be attached to the measurement module.
- a common surface electrode and a reference surface electrode may be added.
- a needle measurement module having a standard bipolar conductor configuration having active and reference electrodes
- the wireless adapter 54 includes a processing unit 90 , a signal interface 92 , a pre-processing stage 94 , an analog-to-digital converter (ADC) 96 , a memory unit 98 , a battery 100 , a transceiver 102 and an antenna 104 connected as shown in FIG. 4 .
- the processing unit 90 controls the operation of the wireless adapter 54 and may be a DSP or the like.
- the electrical interface 92 provides an electrical connection to the active, common and reference leads of the measurement modules 52 or 72 to receive measurement signals 106 .
- the measurement signals 106 are then processed by the pre-processing stage 94 which includes a filtering stage followed by an amplification stage (both not shown).
- the filtering stage includes high pass filters (i.e. one for each of the active and reference measurement signals) to remove the contact potential component from the measurement signals 106 and provide filtered signals. It may also have a sine wave generator used for measuring impedance of the electrodes.
- the cutoff-frequency of the high pass filters is approximately 0.1 Hz to 20 Hz.
- the amplification stage includes a differential amplifier for amplifying the filtered signals thereby providing pre-processed physiological signal 108 .
- the gain factor of the amplifiers is selected so that the pre-processed physiological signal 108 does not saturate the input stage of the ADC 96 . This depends on the type of physiological signals that are measured by the corresponding measurement module 52 or 72 (i.e. since different physiological signals have different amplitudes).
- the particular type of physiological signal that is being measured may be transmitted by the monitoring device 12 to the wireless adapter 54 so that the processing unit 90 can vary the gain of the amplification stage in the pre-processing stage 94 .
- the ADC 96 digitizes the pre-processed physiological signal 108 to provide a digitized physiological signal 110 .
- the processing unit 90 sends the digitized physiological signal 110 to the transceiver 102 for transmitting the corresponding physiological wireless signal 18 via the antenna 104 .
- the wireless physiological signal 18 may be transmitted at different rates depending on the type of physiological measurement that is made.
- the processing unit 90 may store the digitized physiological signals 110 in the memory unit 98 .
- the digitized signals 110 may not be transmitted and may instead simply be stored in the memory unit 98 for downloading at a later time.
- the processing unit 90 may perform further processing on the digitized physiological signals 110 according to the type of physiological signal that is being recorded so that the transceiver 102 sends processed data that corresponds to the measured physiological signal rather than the actual measured physiological signals.
- the processed data may be readily displayed on the display 30 of the monitoring device 12 .
- the processing unit 90 may perform further processing on the digitized physiological signal 110 according to the type of physiological signal that is being recorded so that the transceiver 102 sends averaged data collected over multiple stimulation sweeps.
- the battery 100 of the wireless adapter 54 is a low voltage battery and the other components of the wireless adapter 54 are also adapted for low voltage operation. This reduces the possibility of electrical shock to the patient 16 . In addition, this ensures that the battery 100 can operate for a long time before requiring replacement.
- the battery 100 may be rechargeable and the wireless adapter 54 may have an interface (not shown) to the battery 100 so that the battery 100 can be plugged into a battery charger and recharged.
- any suitable wireless communication protocol may be used for the monitoring device 12 , the wireless sensor 14 and the wireless stimulator 32 .
- the Bluetooth standard is used as the wireless communication protocol.
- the Bluetooth standard provides a universal radio interface in the 2.4 GHz frequency band that enables low power electronic devices to wirelessly communicate with each other.
- the monitoring device 12 , the wireless sensors 14 and the wireless stimulator 32 behave as nodes grouped in an ad-hoc network referred to as a piconet.
- the monitoring device 12 behaves as a master node and the wireless sensors 14 and the wireless stimulator 32 behave as slave nodes.
- the monitoring device 12 and each of the wireless sensors 14 and the wireless stimulator 32 is provided with a unique address so that the wireless physiological signals 18 from various wireless sensors 14 can be distinguished from one another.
- Each node in the Bluetooth network has an internal “native” clock that determines the timing of the corresponding transceiver.
- the communication channel between the master nodes and the slave nodes is defined by a frequency hopping sequence derived from the address of the master node.
- the master node provides its native clock as a time slot reference. Each time slot supports full-duplex communication initiated by the master node: during the first part of the time slot the master node polls a slave node and during the second part of the time slot the corresponding slave node responds.
- the wireless sensors 14 are instructed by the monitoring device 12 to start and stop data transmission so that power and bandwidth is not wasted. Accordingly, the wireless sensors 14 are usually in a “listening mode” to wait for commands from the monitoring device 12 .
- the wireless adapter 54 when the wireless adapter 54 is attached to one of the measurement modules 50 or 70 , the wireless adapter 54 turns on, joins the piconet, identifies itself to monitoring device 12 and listens for commands. The wireless adapter 54 turns off when it is disconnected from the measurement module 50 or 70 .
- physiological monitoring and diagnostic tests performed by the physiological wireless monitoring system 10 require stringent timing requirements for the wireless sensors 14 and/or the wireless stimulator 32 .
- One example is nerve conduction diagnostic tests and evoked potential monitoring in which synchronization is preferably done to within approximately +/ ⁇ 50 microseconds.
- the modulation rate of the master node is approximately 1 Mbit/sec which allows for synchronization down to 1 microsecond. This synchronization can be accomplished by adding extra hardware counting circuitry to the slave nodes, or by using the processors of the slave nodes, to keep track of the modulation rate of the master node. Each slave node will count at the same rate, but will have different zero points based on the time at which they started counting.
- the method of aligning the respective zero points is to have the slave node transmit a timing message to the master node and have the master node immediately respond.
- the slave node measures the number of counts of the master modulation rate taken for the round trip and divides by two to get the transit time. This is done many times, 50 times for example, to get an average transit time and the average clock offset (this is more accurate than individual measurements).
- the slave node then adjusts its native clock based on the average clock offset less the transit time to achieve the stated accuracy. This synchronization procedure is done each time a connection is established between a slave node and the master node.
- Palmar nerve response in which the prongs 44 of the wireless stimulator 32 are placed in contact with the skin above the desired nerve to inject a stimulation current.
- One of the wireless sensors 14 is placed on a finger in close proximity to the desired nerve to measure the resulting action potential of the desired nerve.
- the Palmar nerve response usually occurs in about 1 millisecond. Measuring the latency of this response involves finding the take-off point or peak amplitude of the action potential. An error of 50 microseconds in synchronization results in a 5% error in the response, which is at the limit of what is diagnostically acceptable.
- Some other examples of diagnostic tests and physiological monitoring that can be done with the wireless physiological monitoring system 10 include the blink reflex and recording somatosensory evoked potentials. These tests are demanding in that multiple action potentials are averaged together. This is done since the amplitude of the response is similar to the noise level in the measured signal, which is typically about 1 microvolt. Any errors in timing between stimulus delivery and data acquisition results in a flattened peak in the averaged response making it difficult to determine the latency of the response. If the synchronization errors exceed 50 microseconds then the quality of the responses is considered to be poor.
- Another example of physiological monitoring is the ECG which is typically recorded at a sampling rate of 200 Hz and requires 5 milliseconds of synchronization accuracy.
- Bandwidth may be a factor in some of the monitoring/diagnostic tests that require multiple recording electrodes, such as multimodality monitoring during surgery in which somatosensory evoked potentials, motor evoked potentials, brainstem auditory evoked responses (BAERs), EMG and EEG are simultaneously recorded using up to 16 data channels that each acquire data at a sampling rate of 60 KHz or higher.
- EEG and ECG signals require a sampling rate of 200 Hz
- BAERs require a sampling rate of 60 kHz while most other evoked potentials require a sampling rate of 20 kHz.
- 16 bits are preferably used per sample. This results in a maximum possible data rate of approximately 15 Mbits/sec, which exceeds the capability of the Bluetooth standard, but is still within the range of 802.11 g wireless communication standards.
- the power consumption of devices that operate under the 802.11 g wireless standard is 3 times higher than devices that operate under the Bluetooth communication standard.
- This may be overcome by recording at a high speed triggered by the stimulus and storing the recorded and optionally processed physiological signals in the memory unit 98 of the wireless sensors 14 and then transmitting the recorded physiological signals from the wireless sensors 14 to the monitoring device 12 at lower speeds after the physiological response has occurred.
- This technique is applicable whenever continuous monitoring of the unprocessed waveform data is not required, such as for channels related to evoked potentials where only the averaged signals over multiple recording sweeps need be transmitted.
- the transceiver 102 of the wireless adapter 54 can be turned off when not being used thereby saving power and extending the life of the battery 100 .
- data bandwidth can be reduced by employing at least one of decimation, averaging and compression.
- the power consumption due to the added processing must be smaller than the savings in power consumption due to transmitting a reduced amount of data.
- the wireless physiological monitoring system of the invention is particularly well suited for wireless monitoring of ECG, EMG and EEG monitoring and can be used clinically, intra-operatively and in an Intensive Care Unit (ICU).
- the wireless sensors 14 may be color-coded and/or numbered according to the corresponding placement location on the patient 16 . Accordingly, a medical practitioner simply needs to refer only to the color-coding and/or numbering when attaching the wireless sensors 14 to the patient 16 .
- the wireless physiological monitoring system 10 may further include at least one of a wireless auditory stimulator and a wireless visual stimulator (both not shown).
- the wireless auditory stimulator may be a set of wireless headphones or at least one wireless insert earphone that may be used to present an auditory stimulus to the patient 16 .
- the auditory stimulus may be a steady state waveform such as a tone, or a transient waveform such as a click, or some form of noise or a combination thereof in which the waveforms have a selectable phase, frequency and intensity.
- the wireless visual stimulator may be a set of goggles with a wireless link.
- the goggles may be used to provide steady state or transient visual stimuli such as a flash of light to at least one eye of the patient 16 .
- the wireless sensors 14 are placed at the appropriate location on the patient 16 to record the resulting evoked potential.
Abstract
Embodiments of the invention relate to a wireless physiological monitoring system. The system includes at least one wireless sensor and a monitoring device which are linked to one another of a wireless fashion for measuring physiological signals of a patient. The at least one wireless sensor is located on the patient and may comprise a wireless surface electrode assembly or a wireless needle assembly. The system may also comprise a wireless stimulator syncronized with the wireless sensor for performing certain diagnostic tests, such as nerve conduction velocity tests, for example. The wireless sensor preferably includes active, reference and common conductors. The common conductor can be used to measure the common mode voltage of the patient in the vicinity of the testing, and this voltage can then be subtracted from the measured active and reference voltages.
Description
- This application claims the benefit of U.S. Provisional Patent Application Ser. No. 60/571,944 filed on May 18, 2004, the entire contents of which are hereby incorporated by reference, U.S. Provisional Patent Application Ser. No. 60/571,890, filed on May 18, 2004, the entire contents of which are hereby incorporated by reference and U.S. Provisional Patent Application Ser. No. 60/571,942 filed on May 18, 2004, the entire contents of which are hereby incorporated by reference.
- The invention relates to a wireless physiological monitoring system that can be used to measure a wide variety of physiological signals from a patient for monitoring the patient and/or diagnosing certain medical conditions.
- The measurement of physiological signals from a patient for monitoring the patient and/or diagnosing a particular medical condition conventionally requires medical instrumentation to be physically attached to the patient. This includes attaching electrodes to the patient at the measurement site and then transmitting the measured signals to the medical instrumentation via cables. In some cases, this can result in many cables being connected between the patient and the medical instrumentation. For instance, for multimodality intraoperative monitoring measurements, there may be anywhere from 4 to 32 measurement channels, for electromyography (EMG) measurements there may be 1 to 4 measurement channels, for electrocardiogram (ECG) measurements, there may be ten measurement channels and for measuring brain potentials, there may be more than 128 channels in cases where signals are measured from the cortex.
- The plurality of cables connecting the patient to the medical instrumentation provides many disadvantages. The cables are uncomfortable for the patient and limit the mobility of the patient. It is important for the patient to remain mobile so that the patient does not develop any blood clots. The cables also make it difficult to perform any tests on the patient which require the patient to move. Further, in some cases, the cables may be stiff and can easily become detached from the patient especially when the patient moves.
- The plurality of cables connecting the patient to the medical instrumentation are also cumbersome for the medical personnel that interact with the patient. In particular, the entire set-up can be confusing and in some cases requires expertise for arranging all of the different electrodes and cables. Accordingly, the time required for attaching or removing the electrodes and cables to or from the patient can be quite long. This can be detrimental in situations in which speed is of the essence. In addition, the medical personnel may accidentally trip or become entangled in the cables. Further, in the operating room, the cables to the patient are not accessible during surgery since the cables are in the “sterile field”. This is a problem when troubleshooting faulty cables since cables in the operating room are routinely run over by people and heavy equipment and therefore subject to a high failure rate.
- The inventors have developed a wireless physiological monitoring system that includes, at a minimum, at least one wireless sensor and a monitoring device which are linked to one another in a wireless fashion for measuring physiological signals from a patient for monitoring the patient. The wireless physiological monitoring system may also be used to perform diagnostic tests on the patient. To perform certain diagnostic tests, the wireless physiological monitoring system may further include a wireless stimulator that is synchronized with the wireless sensor for performing certain diagnostic tests such as nerve conduction velocity tests, for example.
- In one instance, the wireless sensor may be a wireless surface electrode assembly. In another instance, the wireless sensor may be a wireless needle assembly. In both cases, the sensors preferably include electrical leads for obtaining active, reference and common voltage measurements. This results in better signal quality for the measured physiological signals since the common mode voltage can be measured and removed from both the measured active and reference voltages. The wireless needle assembly is also advantageous in that it requires no external surface electrodes to operate.
- For both the wireless surface electrode assembly and the wireless needle assembly, the sensors include a releasably attachable wireless adapter that provides a wireless connection between the sensor and the monitoring device, and a measurement module, for measuring physiological signals from the patient. The measurement module is disposable and the wireless adapter may be reused with another measurement module to form another wireless sensor.
- In one instance, the wireless adapter may communicate according to the Bluetooth communication protocol.
- Further, in one embodiment, the wireless adapter includes a processor and a pre-processing stage for processing the measured physiological signals prior to transmitting corresponding wireless signals to the monitoring device. The wireless adapter may also include a memory unit for storing the raw measured or processed physiological signals.
- The wireless physiological monitoring system of the invention advantageously allows for faster application and removal of the sensors to a patient since there are no cables that need to be attached. When the wireless needle assembly is used as the wireless sensor, the medical practitioner simply places the needle assembly into the recording site and receives high quality signals through the wireless connection without the need to prepare and “wire-up” the patient. The wireless physiological monitoring system provides better signal quality for the measured physiological signals since there are no cables which can pick up electromagnetic interference; this is a common problem with conventional equipment. There is also no leakage current once the measured physiological signals have been converted to wireless signals. Furthermore, since all of the components of the wireless physiological monitoring system are totally wireless, the mobility of the patient is not compromised.
- In a first aspect, the invention provides a wireless physiological monitoring system for measuring physiological signals from a patient. The system comprises a monitoring device having a first transceiver; at least one wireless sensor disposed on a measurement site on the patient for measuring a physiological signal, the at least one wireless sensor having a second transceiver for transmitting a corresponding wireless physiological signal to the first transceiver; and, at least one wireless stimulator having a third transceiver, the at least one wireless stimulator being adapted to provide a stimulation current to the patient in response to at least one of a command signal transmitted by the first transceiver of the monitoring device and manual actuation.
- In one embodiment, the at least one wireless sensor includes a wireless adapter having the second transceiver; and, a measurement module having an active conductor and a reference conductor for receiving voltages used to produce a differential voltage measurement indicative of the physiological signal, the measurement module further including a common conductor for receiving another voltage for removing common mode voltage from the differential measurement. The second transceiver transmits the differential measurement as the wireless physiological signal.
- In another embodiment, a wireless surface electrode assembly is used for the at least one wireless sensor. The measurement module of the wireless electrode assembly comprises: a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter; an active electrode for placement on the patient, the active electrode being connected to the active conductor; a reference electrode for placement on the patient, the reference electrode being connected to the reference conductor; and, a common electrode for placement on the patient, the common electrode being connected to the common conductor.
- The active and reference electrodes are located approximately equidistantly from the common electrode.
- In another embodiment, a wireless needle assembly is used for the at least one wireless sensor. The measurement module of the wireless needle assembly comprises: a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter; and, a shaft which houses the active, reference and common conductors, wherein a first conductor is disposed centrally along the longitudinal axis of the shaft, a second conductor is disposed concentrically about the first conductor, a first insulator is disposed in between the first and second conductors, a third conductor is disposed concentrically about the second conductor, and a second insulator is disposed in between the second and third conductors.
- In a second aspect, the invention provides a wireless physiological monitoring system for measuring physiological signals from a patient. The system comprises a monitoring device having a first transceiver; and, at least one wireless sensor disposed on a measurement site on the patient for measuring a physiological signal. The at least one wireless sensor includes a wireless adapter having a second transceiver; and, a measurement module having an active conductor and a reference conductor for receiving voltages used to produce a differential voltage measurement indicative of the physiological signal, the measurement module further including a common conductor for receiving another voltage for removing common mode voltage from the differential measurement. The second transceiver transmits a wireless physiological signal corresponding to the differential voltage measurement to the first transceiver of the monitoring device.
- In one embodiment, the system further comprises at least one wireless stimulator having a third transceiver, the at least one wireless stimulator being adapted to provide a stimulation current to the patient in response to at least one of a command signal transmitted by the first transceiver of the monitoring device and manual actuation.
- In a third aspect, the invention provides a wireless sensor for measuring a physiological signal from a patient, the wireless sensor being disposed on a measurement site on the patient. The wireless sensor comprises: a wireless adapter having a transceiver; and, a measurement module having an active conductor and a reference conductor for receiving voltages used to produce a differential voltage measurement indicative of the physiological signal, the measurement module further including a common conductor for receiving another voltage for removing common mode voltage from the differential measurement. The transceiver transmits a wireless physiological signal corresponding to the differential voltage measurement.
- For a better understanding of the invention and to show more clearly how it may be carried into effect, reference will now be made, by way of example only, to the accompanying drawings which show exemplary embodiments of the invention and in which:
-
FIG. 1 shows an exemplary embodiment of a wireless physiological monitoring system in accordance with the invention; -
FIG. 2 a shows a top view of an exemplary embodiment of a wireless surface electrode assembly for use as a wireless sensor in the system ofFIG. 1 in accordance with the invention; -
FIGS. 2 b shows an exploded side view of an exemplary embodiment of a wireless surface electrode assembly for use as a wireless sensor in the system ofFIG. 1 in accordance with the invention; -
FIG. 3 a shows an exploded side view of an exemplary embodiment of a wireless needle assembly for use as a wireless sensor in the system ofFIG. 1 in accordance with the invention; -
FIG. 3 b shows a magnified view of an exemplary embodiment of the tip of the wireless needle assembly ofFIG. 3 a; and, -
FIG. 4 shows an exemplary embodiment of a wireless adapter for use with either the wireless surface electrode assembly ofFIGS. 2 a and 2 b or the wireless needle assembly ofFIGS. 3 a and 3 b. - It will be appreciated that for simplicity and clarity of illustration, elements shown in the figures have not necessarily been drawn to scale. For example, the dimensions of some of the elements may be exaggerated relative to other elements for clarity. Further, where considered appropriate, reference numerals may be repeated among the figures to indicate corresponding or analogous elements. In addition, numerous specific details are set forth in order to provide a thorough understanding of the invention. However, it will be understood by those of ordinary skill in the art that the invention may be practiced without these specific details. In other instances, well-known methods, procedures and components have not been described in detail so as not to obscure the invention.
- Referring first to
FIG. 1 , shown therein is an exemplary embodiment of a wirelessphysiological monitoring system 10. The wirelessphysiological monitoring system 10 comprises amonitoring device 12 and at least onewireless sensor 14. Typically there are a plurality ofwireless sensors 14, three of which are shown for exemplary purposes. Thewireless sensors 14 are attached to apatient 16 and each measures a desired physiological signal from thepatient 16. Examples of physiological signals include an electroencephalographic (EEG) signal, an electrooculographic (EOG) signal, an electromyographic (EMG) signal or an electrocardiographic (ECG) signal. The measured physiological signal may be pre-processed by thewireless sensor 14. Thewireless sensors 14 then transmit corresponding wirelessphysiological signals 18 to themonitoring device 12. The transmission frequency may be in the Wireless Medical Telemetry Services (WMTS) band or the Industry Scientific and Medical (ISM) band or any other band approved for this activity. The WMTS band includes frequency ranges of 608 to 614 MHz, 1395 to 1400 MHz and 1429 to 1432 MHz. The ISM band includes the frequency range of 2.4 to 2.4835 GHz. The structure of thewireless sensor 14 is discussed in more detail below. - The
monitoring device 12 may perform a number of functions on the wireless physiological signals 18. For instance, themonitoring device 12 may simply store the wirelessphysiological signals 18 for later downloading to a computing device which processes the wireless physiological signals 18. In this case, themonitoring device 12 may simply be a storage device. Alternatively, themonitoring device 12 may itself process the wirelessphysiological signals 18 as well as possibly display the wirelessphysiological signals 18 of the processed version. Accordingly, themonitoring device 12 may be a suitable computing device such as a laptop computer, a personal computer (PC) or an application specific hardware device. - In one exemplary embodiment, the
monitoring device 12 comprises aprocessor 20, amemory unit 22, atransceiver 24 with anantenna 26, apower supply 28 and adisplay 30 connected as shown inFIG. 1 . Theprocessor 20 controls the operation of themonitoring device 12 and initiates monitoring and/or diagnostic tests on thepatient 16 via thewireless sensors 14. In particular, theprocessor 20 sends commands via thetransceiver 24 to thewireless sensors 14 to initiate monitoring or diagnostic tests and also to synchronize with thewireless sensors 14. Theprocessor 20 may be any suitable processing element, such as a PC central processing unit (CPU) chip, and in some instances may be a digital signal processor (DSP). Thetransceiver 24 operates according to a suitable wireless communication protocol. In one instance, the communication protocol may be the Bluetooth communication protocol as discussed in more detail below. - The
processor 20 receives the wirelessphysiological signals 18 and stores the wirelessphysiological signals 18 in thememory unit 22. Thememory unit 22 may be any suitable memory device such as a hard drive or flash memory or the like. The wirelessphysiological signals 18 can then be downloaded, via thetransceiver 24, or another suitable communications device (not shown), to another computing device for processing. Alternatively, prior to storage or after storage, theprocessor 20 may then process the wirelessphysiological signals 18 according to a processing algorithm that is suitable for the type of monitoring or diagnostic test that is being performed. For instance, noise reduction algorithms may be applied to thesignals 18 to improve the signal to noise ratio. In addition, pattern recognition or other detection algorithms may be applied to thesignals 18 to detect certain events in thesignals 18. These noise reduction and pattern recognition algorithms are commonly known to those skilled in the art and will not be discussed further. - The
processor 20 may display the wirelessphysiological signals 18 or the processed version of thesignals 18 on thedisplay unit 30. Thedisplay 30 may be a monitor, an LCD, and the like. Thepower supply 28 provides power to the various components of themonitoring device 12. Thepower supply 28 may be a rechargeable battery or may be a computer power supply unit that is connected to mains power. - The wireless
physiological monitoring system 10 may further comprise at least onewireless stimulator 32 for performing certain diagnostic tests on the patient 16 such as nerve conduction velocity tests. In particular, thewireless stimulator 32 is used to generate a stimulation current to create an action potential in a nerve of thepatient 16. - The
wireless stimulator 32 includes astimulation processor 34, astimulation generation unit 36, a stimulation transceiver 38 with anantenna 40, astimulation interface 42, twoprongs 44 and abattery 46 connected as shown inFIG. 1 . Thewireless stimulator 32 may optionally includebattery charging circuitry 48. Thestimulation processor 34 controls the operation of thewireless stimulator 32 and may be a DSP or a microcontroller. Thestimulation processor 34 instructs thestimulation generation unit 36 to generate a stimulation current when the stimulation transceiver 38 receives an appropriate command signal from themonitoring device 12 or when it is manually actuated. - The
stimulation generation unit 36 includes circuitry to create the stimulation current having different characteristics depending on the part of the patient 16 to which the stimulation current is being applied. In general, the stimulation current is preferably a controlled constant amplitude current and may include a single pulse or multiple pulses where each pulse may be monophasic or biphasic. For example, when the stimulation current is applied to the hand of thepatient 16, the amplitude may be up to 100 milliamps, the duration of up to 1 millisecond and the maximum voltage is limited to 400 volts. However, when thewireless stimulator 32 is applied to the head of thepatient 16, it is used to generate motor-evoked potentials and requires higher amplitude voltages and current. In such an instance, the maximum voltage amplitude is limited to 1000 V, the maximum current amplitude is limited to 1.5 A and the maximum pulse duration is less than 1 ms. - The
stimulation interface 42 allows a medical practitioner to control thewireless stimulator 32. In one embodiment, thestimulation interface 42 includes a button, a dial and a small display (all not shown). The button may be manually actuated to start and stop the stimulation current, and the dial may be used to change the intensity of the stimulation current. The display shows the intensity of the stimulation current and the remaining charge on the battery. Alternatively, as previously mentioned, thewireless stimulator 32 may be controlled from themonitoring device 12 over the wireless link. In both cases, the same level of synchronization is needed between thewireless stimulator 32 and thecorresponding wireless sensors 14 that are used to measure the response to the stimulation current. - During a diagnostic test, the two
prongs 44 of thewireless stimulator 32 are applied to a test site on the skin of the patient 16 to stimulate the desired nerve. One of the prongs is a cathode terminal and the other prong is an anode terminal. Thewireless stimulator 32 also has touch-proof adapter connections (not shown) to stimulate through smaller external electrodes or needles for cases in which theprongs 44 are not appropriate. - The
wireless stimulator 32 is powered by thebattery 46. In one embodiment, thebattery 46 is a rechargeable battery. Accordingly, when thewireless stimulator 32 is not in use, thewireless stimulator 32 is placed in a charging stand (not shown) for recharging thebattery 46. In this case, thestimulation processor 34 engages thebattery charging circuitry 48 to recharge thebattery 46. - There are some diagnostic tests in which it is beneficial to have two wireless stimulators. One example of such a diagnostic test is a collision study. One of the wireless stimulators is used to generate multiple action potentials resulting in a muscle or nerve response from the
patient 16 and the other wireless stimulator is used to generate a second action potential in a different nerve that cancels out an undesirable response detected at the recording site. For this diagnostic test, the timing between the delivery of the stimulation currents provided by the two wireless stimulators must be controlled to an accuracy of a few hundred microseconds. - Referring now to
FIGS. 2 a and 2 b, shown therein is an exemplary wirelesssurface electrode assembly 50 for use as at least one of thewireless sensors 14 in the wirelessphysiological monitoring system 10. The wirelesssurface electrode assembly 50 includes ameasurement module 52 and awireless adapter 54. Themeasurement module 52 includes three conductive electrodes: an active electrode 56, areference electrode 58 and acommon electrode 60. The threeelectrodes common electrode 60 is preferably equidistant to both the active andreference electrodes 56 and 58 so that the voltage measured by thecommon electrode 60 is common to both the active andreference electrodes 56 and 58. The signal provided by thecommon electrode 60 also allows for removing muscle artifacts from the physiological signals measured by the active andreference electrodes 56 and 58. The electrodes can be made of any biocompatible conductive material with suitable mechanical properties, such as silver-silver chloride, gold, silver, tin, platinum or alloys thereof, or carbon. - Each of the
electrodes base 62 of themeasurement module 52 and are electrically insulated from one another. The base may be made of any biocompatible material with suitable mechanical properties, such as Nylon, Teflon or PVC. The base 62 further includes three electrical contacts (not shown) on a top portion thereof that interface with corresponding electrical contacts (not shown) on the bottom of thewireless adapter 54. Thewireless adapter 54 includes components for transmitting the wirelessphysiological signal 18 that corresponds to the physiological signal measured by theelectrode assembly 50 to themonitoring device 12. An exemplary implementation of thewireless adapter 54 is described below. - The
wireless adapter 54 has a shape that is complementary to that of themeasurement module 52 so that thewireless adapter 54 makes a snap-fit or friction-fit connection with themeasurement module 52. The connection is also such that thewireless adapter 54 is releasably attachable to themeasurement module 52. Accordingly, thewireless adapter 54 can be attached to ameasurement module 52, used for physiological monitoring or diagnostic testing on thepatient 16, and then detached from themeasurement module 52 once monitoring/testing is completed so that thewireless adapter 54 can be reused and themeasurement module 52 can be discarded. - The wireless
surface electrode assembly 50 further includes an adhesive portion preferably applied to a section of each of theelectrodes surface electrode assembly 50 in place once theassembly 50 has been attached to thepatient 16. Alternatively, or in addition, a piece of tape, or other adhesive means, may be applied to theelectrodes surface electrode assembly 50 to hold it in place. The electrodes may also be glued on with a suitable glue such as collodion. Alternatively, the wirelesssurface electrode assembly 50 may be built into gloves that are worn and held in place by a medical practitioner that is obtaining physiological signals from thepatient 16. - Referring now to
FIGS. 3 a and 3 b, shown therein are an exploded side view, and a magnified view of the tip, respectively, of an exemplary embodiment of a wireless needle assembly 70, for use as at least one of thewireless sensors 14 in the wirelessphysiological monitoring system 10. - The wireless needle assembly 70 includes a measurement module 72 and the
wireless adapter 54. The measurement module 72 includes a shaft with aneedle tip 74 disposed at the end; the shaft and needle tip having three concentric conductors: an active conductor 76, areference conductor 78 and acommon conductor 80. The active andreference conductors 76 and 78 are separated by aninsulator 82. The reference andcommon conductors insulator 84. The threeconductors wireless sensor 50, so that a differential measurement may be made for the desired physiological signal and so that the common mode component of the differential measurement may be removed. - The
common conductor 80 is advantageously in close proximity to both of the active conductor 76 and thereference conductor 78 so that it provides a close approximation to the common mode voltage of the active andreference conductors 76 and 78. It should be noted that the location of the reference, common andactive conductors outer electrode 80 may be the active conductor. However, it is preferable for the active andreference conductors 76 and 78 to remain close to one another to eliminate any far field effects in the measured voltages. Accordingly, thecommon conductor 80 is preferably the outer conductor. - Each of the
conductors base 86 of the measurement module 72. The base 86 further includes three electrical contacts on a top portion thereof that interface with corresponding electrical contacts on the bottom of thewireless adapter 54. Similar to the wirelesssurface electrode assembly 50, thewireless adapter 54 has a shape that is complementary to that of the measurement module 72 so that thewireless adapter 54 is releasably attachable to the measurement module 72. Accordingly, thewireless adapter 52 is reusable and the measurement module 72 is disposable. The entire wireless needle assembly 70 is small enough to facilitate clinical use. Further, thetip 74 of the wireless needle assembly 70 may come in different lengths and diameters to facilitate measurement at muscles or nerves of different sizes and depths. Further details of the needle used by wireless needle assembly 70 are shown and described in co-pending U.S. patent application Ser. No. ______, filed May 17, 2005 and entitled “Needle Having Multiple Electrodes”, the entire contents of which is hereby incorporated by reference. - In use, the wireless needle assembly 70 is inserted into a desired measurement site on the patient. To hold the wireless needle assembly 70 in place, a piece of tape, or other adhesive means, may be applied to the wireless needle assembly 70. The wireless needle assembly 70 may also be held in place by the hand of the medical practitioner who is measuring physiological signals from the
patient 16. Alternatively, the wireless needle assembly 70 may not need any tape or adhesive if it is inserted to an adequate depth. In another alternative, the tip of the wireless needle assembly 70 may have a hook or corkscrew shape to hold it in place. - It should also be noted that the
wireless adapter 54 may be used with other needles having a different number of conductors. For instance, thewireless adapter 54 may be combined with a measurement module that has a standard monopolar conductor configuration or with a measurement module that has a standard bipolar conductor configuration. In these cases, if a differential voltage measurement is to be made while removing common-mode voltage, extra surface electrodes can be attached to the measurement module. For instance, in the case of a needle measurement module having a standard monopolar (single active electrode) conductor configuration, a common surface electrode and a reference surface electrode may be added. In the case of a needle measurement module having a standard bipolar conductor configuration (having active and reference electrodes), only a common surface electrode need be added. - Referring now to
FIG. 4 , shown therein is an exemplary embodiment of thewireless adapter 54 for use with either the wirelesssurface electrode assembly 60 or the wireless needle assembly 70. Thewireless adapter 54 includes aprocessing unit 90, asignal interface 92, apre-processing stage 94, an analog-to-digital converter (ADC) 96, amemory unit 98, abattery 100, atransceiver 102 and anantenna 104 connected as shown inFIG. 4 . Theprocessing unit 90 controls the operation of thewireless adapter 54 and may be a DSP or the like. - The
electrical interface 92 provides an electrical connection to the active, common and reference leads of themeasurement modules 52 or 72 to receive measurement signals 106. The measurement signals 106 are then processed by thepre-processing stage 94 which includes a filtering stage followed by an amplification stage (both not shown). The filtering stage includes high pass filters (i.e. one for each of the active and reference measurement signals) to remove the contact potential component from the measurement signals 106 and provide filtered signals. It may also have a sine wave generator used for measuring impedance of the electrodes. The cutoff-frequency of the high pass filters is approximately 0.1 Hz to 20 Hz. - The amplification stage includes a differential amplifier for amplifying the filtered signals thereby providing pre-processed
physiological signal 108. The gain factor of the amplifiers is selected so that the pre-processedphysiological signal 108 does not saturate the input stage of theADC 96. This depends on the type of physiological signals that are measured by thecorresponding measurement module 52 or 72 (i.e. since different physiological signals have different amplitudes). The particular type of physiological signal that is being measured may be transmitted by themonitoring device 12 to thewireless adapter 54 so that theprocessing unit 90 can vary the gain of the amplification stage in thepre-processing stage 94. - The
ADC 96 digitizes the pre-processedphysiological signal 108 to provide a digitizedphysiological signal 110. Theprocessing unit 90 sends the digitizedphysiological signal 110 to thetransceiver 102 for transmitting the correspondingphysiological wireless signal 18 via theantenna 104. The wirelessphysiological signal 18 may be transmitted at different rates depending on the type of physiological measurement that is made. - Prior to sending the digitized
physiological signals 110 to thetransceiver 102, theprocessing unit 90 may store the digitizedphysiological signals 110 in thememory unit 98. In an alternative, the digitizedsignals 110 may not be transmitted and may instead simply be stored in thememory unit 98 for downloading at a later time. - In another alternative, the
processing unit 90 may perform further processing on the digitizedphysiological signals 110 according to the type of physiological signal that is being recorded so that thetransceiver 102 sends processed data that corresponds to the measured physiological signal rather than the actual measured physiological signals. The processed data may be readily displayed on thedisplay 30 of themonitoring device 12. In another alternative, theprocessing unit 90 may perform further processing on the digitizedphysiological signal 110 according to the type of physiological signal that is being recorded so that thetransceiver 102 sends averaged data collected over multiple stimulation sweeps. - The
battery 100 of thewireless adapter 54 is a low voltage battery and the other components of thewireless adapter 54 are also adapted for low voltage operation. This reduces the possibility of electrical shock to thepatient 16. In addition, this ensures that thebattery 100 can operate for a long time before requiring replacement. In an alternative, thebattery 100 may be rechargeable and thewireless adapter 54 may have an interface (not shown) to thebattery 100 so that thebattery 100 can be plugged into a battery charger and recharged. - Any suitable wireless communication protocol may be used for the
monitoring device 12, thewireless sensor 14 and thewireless stimulator 32. In one embodiment, the Bluetooth standard is used as the wireless communication protocol. The Bluetooth standard provides a universal radio interface in the 2.4 GHz frequency band that enables low power electronic devices to wirelessly communicate with each other. In accordance with the Bluetooth standard, themonitoring device 12, thewireless sensors 14 and thewireless stimulator 32 behave as nodes grouped in an ad-hoc network referred to as a piconet. Themonitoring device 12 behaves as a master node and thewireless sensors 14 and thewireless stimulator 32 behave as slave nodes. Themonitoring device 12 and each of thewireless sensors 14 and thewireless stimulator 32 is provided with a unique address so that the wirelessphysiological signals 18 fromvarious wireless sensors 14 can be distinguished from one another. - Each node in the Bluetooth network has an internal “native” clock that determines the timing of the corresponding transceiver. The communication channel between the master nodes and the slave nodes is defined by a frequency hopping sequence derived from the address of the master node. The master node provides its native clock as a time slot reference. Each time slot supports full-duplex communication initiated by the master node: during the first part of the time slot the master node polls a slave node and during the second part of the time slot the corresponding slave node responds.
- During operation, the
wireless sensors 14 are instructed by themonitoring device 12 to start and stop data transmission so that power and bandwidth is not wasted. Accordingly, thewireless sensors 14 are usually in a “listening mode” to wait for commands from themonitoring device 12. In particular, when thewireless adapter 54 is attached to one of themeasurement modules 50 or 70, thewireless adapter 54 turns on, joins the piconet, identifies itself to monitoringdevice 12 and listens for commands. Thewireless adapter 54 turns off when it is disconnected from themeasurement module 50 or 70. - Some of the physiological monitoring and diagnostic tests performed by the physiological
wireless monitoring system 10 require stringent timing requirements for thewireless sensors 14 and/or thewireless stimulator 32. One example is nerve conduction diagnostic tests and evoked potential monitoring in which synchronization is preferably done to within approximately +/−50 microseconds. - With the Bluetooth communication standard, the modulation rate of the master node is approximately 1 Mbit/sec which allows for synchronization down to 1 microsecond. This synchronization can be accomplished by adding extra hardware counting circuitry to the slave nodes, or by using the processors of the slave nodes, to keep track of the modulation rate of the master node. Each slave node will count at the same rate, but will have different zero points based on the time at which they started counting.
- The method of aligning the respective zero points is to have the slave node transmit a timing message to the master node and have the master node immediately respond. The slave node then measures the number of counts of the master modulation rate taken for the round trip and divides by two to get the transit time. This is done many times, 50 times for example, to get an average transit time and the average clock offset (this is more accurate than individual measurements). The slave node then adjusts its native clock based on the average clock offset less the transit time to achieve the stated accuracy. This synchronization procedure is done each time a connection is established between a slave node and the master node.
- An example of a diagnostic test that can be performed with the wireless
physiological monitoring system 10 is the Palmar nerve response, in which theprongs 44 of thewireless stimulator 32 are placed in contact with the skin above the desired nerve to inject a stimulation current. One of thewireless sensors 14 is placed on a finger in close proximity to the desired nerve to measure the resulting action potential of the desired nerve. The Palmar nerve response usually occurs in about 1 millisecond. Measuring the latency of this response involves finding the take-off point or peak amplitude of the action potential. An error of 50 microseconds in synchronization results in a 5% error in the response, which is at the limit of what is diagnostically acceptable. - Some other examples of diagnostic tests and physiological monitoring that can be done with the wireless
physiological monitoring system 10 include the blink reflex and recording somatosensory evoked potentials. These tests are demanding in that multiple action potentials are averaged together. This is done since the amplitude of the response is similar to the noise level in the measured signal, which is typically about 1 microvolt. Any errors in timing between stimulus delivery and data acquisition results in a flattened peak in the averaged response making it difficult to determine the latency of the response. If the synchronization errors exceed 50 microseconds then the quality of the responses is considered to be poor. Another example of physiological monitoring is the ECG which is typically recorded at a sampling rate of 200 Hz and requires 5 milliseconds of synchronization accuracy. - Bandwidth may be a factor in some of the monitoring/diagnostic tests that require multiple recording electrodes, such as multimodality monitoring during surgery in which somatosensory evoked potentials, motor evoked potentials, brainstem auditory evoked responses (BAERs), EMG and EEG are simultaneously recorded using up to 16 data channels that each acquire data at a sampling rate of 60 KHz or higher. Actually EEG and ECG signals require a sampling rate of 200 Hz, BAERs require a sampling rate of 60 kHz while most other evoked potentials require a sampling rate of 20 kHz. In addition, 16 bits are preferably used per sample. This results in a maximum possible data rate of approximately 15 Mbits/sec, which exceeds the capability of the Bluetooth standard, but is still within the range of 802.11 g wireless communication standards.
- Unfortunately, the power consumption of devices that operate under the 802.11 g wireless standard is 3 times higher than devices that operate under the Bluetooth communication standard. This may be overcome by recording at a high speed triggered by the stimulus and storing the recorded and optionally processed physiological signals in the
memory unit 98 of thewireless sensors 14 and then transmitting the recorded physiological signals from thewireless sensors 14 to themonitoring device 12 at lower speeds after the physiological response has occurred. This technique is applicable whenever continuous monitoring of the unprocessed waveform data is not required, such as for channels related to evoked potentials where only the averaged signals over multiple recording sweeps need be transmitted. - However, this technique does not work for channels related to EMG data which require continuous data transmission, but the EMG data can be sampled at lower frequencies.
- It should further be noted that by storing and transmitting the data periodically, the
transceiver 102 of thewireless adapter 54 can be turned off when not being used thereby saving power and extending the life of thebattery 100. In addition, to save power consumption, data bandwidth can be reduced by employing at least one of decimation, averaging and compression. However, the power consumption due to the added processing must be smaller than the savings in power consumption due to transmitting a reduced amount of data. - The wireless physiological monitoring system of the invention is particularly well suited for wireless monitoring of ECG, EMG and EEG monitoring and can be used clinically, intra-operatively and in an Intensive Care Unit (ICU). In use, the
wireless sensors 14 may be color-coded and/or numbered according to the corresponding placement location on thepatient 16. Accordingly, a medical practitioner simply needs to refer only to the color-coding and/or numbering when attaching thewireless sensors 14 to thepatient 16. - In order to conduct auditory or visual evoked potential testing, the wireless
physiological monitoring system 10 may further include at least one of a wireless auditory stimulator and a wireless visual stimulator (both not shown). The wireless auditory stimulator may be a set of wireless headphones or at least one wireless insert earphone that may be used to present an auditory stimulus to thepatient 16. The auditory stimulus may be a steady state waveform such as a tone, or a transient waveform such as a click, or some form of noise or a combination thereof in which the waveforms have a selectable phase, frequency and intensity. The wireless visual stimulator may be a set of goggles with a wireless link. The goggles may be used to provide steady state or transient visual stimuli such as a flash of light to at least one eye of thepatient 16. In both the auditory and visual cases, thewireless sensors 14 are placed at the appropriate location on the patient 16 to record the resulting evoked potential. - It should be understood that various modifications can be made to the embodiments described and illustrated herein, without departing from the invention.
Claims (27)
1. A wireless physiological monitoring system for measuring physiological signals from a patient, comprising:
a monitoring device having a first transceiver;
at least one wireless sensor disposed on a measurement site on the patient for measuring a physiological signal, the at least one wireless sensor having a second transceiver for transmitting a corresponding wireless physiological signal to the first transceiver; and
at least one wireless stimulator having a third transceiver, the at least one wireless stimulator being adapted to provide a stimulation current to the patient in response to at least one of a command signal transmitted by the first transceiver of the monitoring device and manual actuation.
2. The system of claim 1 , wherein the at least one wireless sensor includes a wireless adapter comprising:
the second transceiver; and
a measurement module having an active conductor and a reference conductor for receiving voltages used to produce a differential voltage measurement indicative of the physiological signal, the measurement module further including a common conductor for receiving another voltage for removing common mode voltage from the differential measurement.
3. The system of claim 2 , wherein the second transceiver transmits the differential measurement as the wireless physiological signal.
4. The system of claim 3 , wherein the at least one wireless sensor comprises a wireless surface electrode assembly comprising the measurement module.
5. The system of claim 4 , wherein the measurement module of the wireless electrode assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter;
an active electrode for placement on the patient, the active electrode being connected to the active conductor;
a reference electrode for placement on the patient, the reference electrode being connected to the reference conductor; and
a common electrode for placement on the patient, the common electrode being connected to the common conductor.
6. The system of claim 5 , wherein the active and reference electrodes are located approximately equidistantly from the common electrode.
7. The system of claim 3 , wherein the at least one wireless sensor comprises a wireless needle assembly comprising the measurement module.
8. The system of claim 7 , wherein the measurement module of the wireless needle assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter; and
a shaft which houses the active, reference and common conductors, wherein a first conductor is disposed centrally along the longitudinal axis of the shaft, a second conductor is disposed concentrically about the first conductor, a first insulator is disposed in between the first and second conductors, a third conductor is disposed concentrically about the second conductor, and a second insulator is disposed in between the second and third conductors.
9. The system of claim 7 , wherein the measurement module of the wireless needle assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter;
a needle shaft comprising the active and reference conductors; and
a surface electrode comprising the common conductor.
10. The system of claim 7 , wherein the measurement module of the wireless needle assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter;
a needle shaft comprising the active conductor; and
surface electrodes comprising the reference and common conductors, respectively.
11. A wireless physiological monitoring system for measuring physiological signals from a patient, comprising:
a monitoring device having a first transceiver;
at least one wireless sensor disposed on a measurement site on the patient for measuring a physiological signal, the at least one wireless sensor including a wireless adapter having a second transceiver; and
a measurement module having an active conductor and a reference conductor for receiving voltages used to produce a differential voltage measurement indicative of the physiological signal, the measurement module further including a common conductor for receiving another voltage for removing common mode voltage from the differential measurement;
12. The system of claim 11 , wherein the second transceiver transmits the differential measurement as the wireless physiological signal.
13. The system of claim 12 , wherein the at least one wireless sensor comprises a wireless surface electrode assembly comprising the measurement module.
14. The system of claim 13 , wherein the measurement module of the wireless electrode assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter;
an active electrode for placement on the patient, the active electrode being connected to the active conductor;
a reference electrode for placement on the patient, the reference electrode being connected to the reference conductor; and
a common electrode for placement on the patient, the common electrode being connected to the common conductor.
15. The system of claim 14 , wherein the active and reference electrodes are located approximately equidistantly from the common electrode.
16. The system of claim 12 , wherein the at least one wireless sensor comprises a wireless needle assembly comprising the measurement module.
17. The system of claim 16 , wherein the measurement module of the wireless needle assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter; and
a shaft which houses the active, reference and common conductors, wherein a first conductor is disposed centrally along the longitudinal axis of the shaft, a second conductor is disposed concentrically about the first conductor, a first insulator is disposed in between the first and second conductors, a third conductor is disposed concentrically about the second conductor, and a second insulator is disposed in between the second and third conductors.
18. The system of claim 16 , wherein the measurement module of the wireless needle assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter;
a needle shaft comprising the active and reference conductors; and
a surface electrode comprising the common conductor.
19. The system of claim 16 , wherein the measurement module of the wireless needle assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter;
a needle shaft comprising the active conductor; and
surface electrodes comprising the reference and common conductors, respectively.
20. A wireless sensor for measuring a physiological signal from a patient, the wireless sensor being disposed on a measurement site on the patient, the system comprising:
a wireless adapter having a transceiver
a measurement module having an active conductor and a reference conductor for receiving voltages used to produce a differential voltage measurement indicative of the physiologicial signal, the measurement module further including a common conductor for receiving another voltage for removing common mode voltage from the differential measurement, wherein the transceiver transmits a wireless physiological signal corresponding to the differential voltage measurement.
21. The sensor of claim 20 , wherein the wireless sensor comprises a wireless surface electrode assembly.
22. The sensor of claim 21 , wherein the measurement module of the wireless electrode assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter;
an active electrode for placement on the patient, the active electrode being connected to the active conductor;
a reference electrode for placement on the patient, the reference electrode being connected to the reference conductor; and
a common electrode for placement on the patient, the common electrode being connected to the common conductor.
23. The sensor of claim 22 , wherein the active and reference electrodes are located approximately equidistantly from the common electrode.
24. The sensor of claim 20 , wherein the wireless sensor comprises a wireless needle assembly.
25. The sensor of claim 24 , wherein the measurement module of the wireless needle assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter; and
a shaft which houses the active, reference and common conductors, wherein a first conductor is disposed centrally along the longitudinal axis of the shaft, a second conductor is disposed concentrically about the first conductor, a first insulator is disposed in between the first and second conductors, a third conductor is disposed concentrically about the second conductor, and a second insulator is disposed in between the second and third conductors.
26. The sensor of claim 24 , wherein the measurement module of the wireless needle assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter;
a needle shaft comprising the active and reference conductors; and
a surface electrode comprising the common conductor.
27. The sensor of claim 24 , wherein the measurement module of the wireless needle assembly comprises:
a base having an electrical interface connected to the active, reference and common conductors, the base having a shape complementary to that of the wireless adapter for releasable attachment to the wireless adapter;
a needle shaft comprising the active conductor; and
surface electrodes comprising the reference and common conductors, respectively.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/130,221 US20050261559A1 (en) | 2004-05-18 | 2005-05-17 | Wireless physiological monitoring system |
US12/332,105 US8805527B2 (en) | 2004-05-18 | 2008-12-10 | Wireless physiological monitoring |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57194204P | 2004-05-18 | 2004-05-18 | |
US57189004P | 2004-05-18 | 2004-05-18 | |
US57194404P | 2004-05-18 | 2004-05-18 | |
US11/130,221 US20050261559A1 (en) | 2004-05-18 | 2005-05-17 | Wireless physiological monitoring system |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/332,105 Continuation US8805527B2 (en) | 2004-05-18 | 2008-12-10 | Wireless physiological monitoring |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050261559A1 true US20050261559A1 (en) | 2005-11-24 |
Family
ID=35376119
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/130,221 Abandoned US20050261559A1 (en) | 2004-05-18 | 2005-05-17 | Wireless physiological monitoring system |
US12/332,105 Active 2029-09-22 US8805527B2 (en) | 2004-05-18 | 2008-12-10 | Wireless physiological monitoring |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/332,105 Active 2029-09-22 US8805527B2 (en) | 2004-05-18 | 2008-12-10 | Wireless physiological monitoring |
Country Status (1)
Country | Link |
---|---|
US (2) | US20050261559A1 (en) |
Cited By (104)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050268916A1 (en) * | 2004-05-18 | 2005-12-08 | Mumford John R | Mask assembly with integrated sensors |
US20060071934A1 (en) * | 2004-10-01 | 2006-04-06 | Sony Corporation | System and method for tracking facial muscle and eye motion for computer graphics animation |
US20060258930A1 (en) * | 2004-05-18 | 2006-11-16 | Jianping Wu | Device for use in sleep stage determination using frontal electrodes |
US20070027388A1 (en) * | 2005-08-01 | 2007-02-01 | Chang-An Chou | Patch-type physiological monitoring apparatus, system and network |
US20070033069A1 (en) * | 2005-08-08 | 2007-02-08 | Rajendra Rao | Fitness network system |
GB2430038A (en) * | 2005-08-12 | 2007-03-14 | Draeger Medical Ag | Housing System For Medical Sensors |
US20070135866A1 (en) * | 2005-12-14 | 2007-06-14 | Welch Allyn Inc. | Medical device wireless adapter |
US20070146370A1 (en) * | 2005-12-23 | 2007-06-28 | Demian Gordon | Group tracking in motion capture |
US20070208269A1 (en) * | 2004-05-18 | 2007-09-06 | Mumford John R | Mask assembly, system and method for determining the occurrence of respiratory events using frontal electrode array |
WO2007091193A3 (en) * | 2006-02-09 | 2007-12-13 | Koninkl Philips Electronics Nv | Device for monitoring the status of a patient and treatment based thereupon |
WO2008012398A1 (en) * | 2006-07-25 | 2008-01-31 | Mediracer Ltd. | Method and equipment for controlling the measurement of nerve response wirelessly |
US20080125288A1 (en) * | 2006-04-20 | 2008-05-29 | Nike, Inc. | Systems for activating and/or authenticating electronic devices for operation with apparel and equipment |
WO2008076372A2 (en) * | 2006-12-15 | 2008-06-26 | Neurometrix, Inc. | Neurological diagnostic and therapeutic system utilizing function-specific modules |
US20080154111A1 (en) * | 2006-12-22 | 2008-06-26 | Jianping Wu | Method, system and device for sleep stage determination using frontal electrodes |
US20080306348A1 (en) * | 2007-06-06 | 2008-12-11 | National Yang-Ming University | Miniature wireless apparatus for recording physiological signals of humans and use thereof |
US20090024044A1 (en) * | 2007-07-17 | 2009-01-22 | The General Electric Company | Data recording for patient status analysis |
US20090085768A1 (en) * | 2007-10-02 | 2009-04-02 | Medtronic Minimed, Inc. | Glucose sensor transceiver |
US20090299214A1 (en) * | 2007-05-11 | 2009-12-03 | Changwang Wu | Method and apparatus for quantitative nerve localization |
US20100063365A1 (en) * | 2005-04-14 | 2010-03-11 | Hidalgo Limited | Apparatus and System for Monitoring |
US20110009729A1 (en) * | 2009-07-08 | 2011-01-13 | Electronics And Telecommunications Research Institute | Apparatus for measuring physiological signals |
US7978064B2 (en) | 2005-04-28 | 2011-07-12 | Proteus Biomedical, Inc. | Communication system with partial power source |
US8036748B2 (en) | 2008-11-13 | 2011-10-11 | Proteus Biomedical, Inc. | Ingestible therapy activator system and method |
US8055334B2 (en) | 2008-12-11 | 2011-11-08 | Proteus Biomedical, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
US8054140B2 (en) | 2006-10-17 | 2011-11-08 | Proteus Biomedical, Inc. | Low voltage oscillator for medical devices |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
US8114021B2 (en) | 2008-12-15 | 2012-02-14 | Proteus Biomedical, Inc. | Body-associated receiver and method |
US8258962B2 (en) | 2008-03-05 | 2012-09-04 | Proteus Biomedical, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
WO2013134776A1 (en) * | 2012-03-09 | 2013-09-12 | Natus Medical Incorporated | Performance concentric electromyography needle |
US8540664B2 (en) | 2009-03-25 | 2013-09-24 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
US8540633B2 (en) | 2008-08-13 | 2013-09-24 | Proteus Digital Health, Inc. | Identifier circuits for generating unique identifiable indicators and techniques for producing same |
US8545402B2 (en) | 2009-04-28 | 2013-10-01 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US8547248B2 (en) | 2005-09-01 | 2013-10-01 | Proteus Digital Health, Inc. | Implantable zero-wire communications system |
US8558563B2 (en) | 2009-08-21 | 2013-10-15 | Proteus Digital Health, Inc. | Apparatus and method for measuring biochemical parameters |
US8579794B2 (en) | 2008-05-02 | 2013-11-12 | Dymedix Corporation | Agitator to stimulate the central nervous system |
US8597186B2 (en) | 2009-01-06 | 2013-12-03 | Proteus Digital Health, Inc. | Pharmaceutical dosages delivery system |
US20140100432A1 (en) * | 2012-10-07 | 2014-04-10 | George Stefan Golda | Wearable Cardiac Monitor |
US8718193B2 (en) | 2006-11-20 | 2014-05-06 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
US8730031B2 (en) | 2005-04-28 | 2014-05-20 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US8747313B2 (en) * | 2006-05-12 | 2014-06-10 | Bao Tran | Health monitoring appliance |
US8784308B2 (en) | 2009-12-02 | 2014-07-22 | Proteus Digital Health, Inc. | Integrated ingestible event marker system with pharmaceutical product |
US20140203950A1 (en) * | 2011-07-21 | 2014-07-24 | Mark Zdeblick | Mobile Communication Device, System, and Method |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US8834346B2 (en) | 2008-08-22 | 2014-09-16 | Dymedix Corporation | Stimulus sequencer for a closed loop neuromodulator |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8858432B2 (en) | 2007-02-01 | 2014-10-14 | Proteus Digital Health, Inc. | Ingestible event marker systems |
US8868453B2 (en) | 2009-11-04 | 2014-10-21 | Proteus Digital Health, Inc. | System for supply chain management |
US8870791B2 (en) | 2006-03-23 | 2014-10-28 | Michael E. Sabatino | Apparatus for acquiring, processing and transmitting physiological sounds |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
US8932221B2 (en) | 2007-03-09 | 2015-01-13 | Proteus Digital Health, Inc. | In-body device having a multi-directional transmitter |
US8945005B2 (en) | 2006-10-25 | 2015-02-03 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
US8956287B2 (en) | 2006-05-02 | 2015-02-17 | Proteus Digital Health, Inc. | Patient customized therapeutic regimens |
US8956288B2 (en) | 2007-02-14 | 2015-02-17 | Proteus Digital Health, Inc. | In-body power source having high surface area electrode |
US8961412B2 (en) | 2007-09-25 | 2015-02-24 | Proteus Digital Health, Inc. | In-body device with virtual dipole signal amplification |
US8968195B2 (en) | 2006-05-12 | 2015-03-03 | Bao Tran | Health monitoring appliance |
US9014779B2 (en) | 2010-02-01 | 2015-04-21 | Proteus Digital Health, Inc. | Data gathering system |
US9028405B2 (en) | 2006-05-16 | 2015-05-12 | Bao Tran | Personal monitoring system |
US9060683B2 (en) | 2006-05-12 | 2015-06-23 | Bao Tran | Mobile wireless appliance |
US9107806B2 (en) | 2010-11-22 | 2015-08-18 | Proteus Digital Health, Inc. | Ingestible device with pharmaceutical product |
US9149423B2 (en) | 2009-05-12 | 2015-10-06 | Proteus Digital Health, Inc. | Ingestible event markers comprising an ingestible component |
US20150316594A1 (en) * | 2014-04-30 | 2015-11-05 | Jason Kania | Energy Monitoring and Analysis System |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
US9270025B2 (en) | 2007-03-09 | 2016-02-23 | Proteus Digital Health, Inc. | In-body device having deployable antenna |
US9268909B2 (en) | 2012-10-18 | 2016-02-23 | Proteus Digital Health, Inc. | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
US9270503B2 (en) | 2013-09-20 | 2016-02-23 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US9271897B2 (en) | 2012-07-23 | 2016-03-01 | Proteus Digital Health, Inc. | Techniques for manufacturing ingestible event markers comprising an ingestible component |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
US9439599B2 (en) | 2011-03-11 | 2016-09-13 | Proteus Digital Health, Inc. | Wearable personal body associated device with various physical configurations |
US9492105B1 (en) * | 2009-02-13 | 2016-11-15 | Cleveland Medical Devices Inc. | Device for sleep diagnosis |
JP2017502711A (en) * | 2013-11-07 | 2017-01-26 | セーフオプ サージカル インコーポレイテッド | System and method for detecting neural function |
US9577864B2 (en) | 2013-09-24 | 2017-02-21 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US9597487B2 (en) | 2010-04-07 | 2017-03-21 | Proteus Digital Health, Inc. | Miniature ingestible device |
US9603550B2 (en) | 2008-07-08 | 2017-03-28 | Proteus Digital Health, Inc. | State characterization based on multi-variate data fusion techniques |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
US9865176B2 (en) | 2012-12-07 | 2018-01-09 | Koninklijke Philips N.V. | Health monitoring system |
US9883819B2 (en) | 2009-01-06 | 2018-02-06 | Proteus Digital Health, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
US9913509B2 (en) | 2005-06-27 | 2018-03-13 | Nike, Inc. | Systems for activating and/or authenticating electronic devices for operation with footwear and other uses |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
WO2018216003A1 (en) * | 2017-05-25 | 2018-11-29 | Nanovation G.S. Ltd | Non-invasive device and method for sensing respiratory parameters |
US10175376B2 (en) | 2013-03-15 | 2019-01-08 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
US20190015048A1 (en) * | 2017-07-14 | 2019-01-17 | Welch Allyn, Inc. | Physical parameter measuring |
US10187121B2 (en) | 2016-07-22 | 2019-01-22 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
US10244949B2 (en) | 2012-10-07 | 2019-04-02 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US10265514B2 (en) | 2014-02-14 | 2019-04-23 | Medtronic, Inc. | Sensing and stimulation system |
USD850626S1 (en) | 2013-03-15 | 2019-06-04 | Rhythm Diagnostic Systems, Inc. | Health monitoring apparatuses |
US10398161B2 (en) | 2014-01-21 | 2019-09-03 | Proteus Digital Heal Th, Inc. | Masticable ingestible product and communication system therefor |
US10529044B2 (en) | 2010-05-19 | 2020-01-07 | Proteus Digital Health, Inc. | Tracking and delivery confirmation of pharmaceutical products |
US10610111B1 (en) | 2006-06-30 | 2020-04-07 | Bao Tran | Smart watch |
US10610159B2 (en) | 2012-10-07 | 2020-04-07 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US11026627B2 (en) | 2013-03-15 | 2021-06-08 | Cadwell Laboratories, Inc. | Surgical instruments for determining a location of a nerve during a procedure |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
US11149123B2 (en) | 2013-01-29 | 2021-10-19 | Otsuka Pharmaceutical Co., Ltd. | Highly-swellable polymeric films and compositions comprising the same |
US11158149B2 (en) | 2013-03-15 | 2021-10-26 | Otsuka Pharmaceutical Co., Ltd. | Personal authentication apparatus system and method |
US11177610B2 (en) | 2017-01-23 | 2021-11-16 | Cadwell Laboratories, ino. | Neuromonitoring connection system |
US11253182B2 (en) | 2018-05-04 | 2022-02-22 | Cadwell Laboratories, Inc. | Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation |
JPWO2022163382A1 (en) * | 2021-01-27 | 2022-08-04 | ||
US11443649B2 (en) | 2018-06-29 | 2022-09-13 | Cadwell Laboratories, Inc. | Neurophysiological monitoring training simulator |
US20220338792A1 (en) * | 2020-04-05 | 2022-10-27 | Epitel, Inc. | Eeg recording and analysis |
US11529071B2 (en) | 2016-10-26 | 2022-12-20 | Otsuka Pharmaceutical Co., Ltd. | Methods for manufacturing capsules with ingestible event markers |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
US11857330B1 (en) | 2022-10-19 | 2024-01-02 | Epitel, Inc. | Systems and methods for electroencephalogram monitoring |
US11903700B2 (en) | 2019-08-28 | 2024-02-20 | Rds | Vital signs monitoring systems and methods |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8290577B2 (en) * | 2007-03-23 | 2012-10-16 | Brooks Donald J | Methods and apparatus for enhanced fiducial point determination and non-invasive hemodynamic parameter determination |
US8063770B2 (en) * | 2007-08-01 | 2011-11-22 | Peter Costantino | System and method for facial nerve monitoring |
US8680986B2 (en) * | 2007-08-01 | 2014-03-25 | Peter Costantino | System and method for facial nerve monitoring during facial surgery |
US20090281448A1 (en) * | 2008-05-10 | 2009-11-12 | Neural Signals, Inc. | Wireless Skin Surface Potential Sensing System and Method |
US8971936B2 (en) * | 2009-09-01 | 2015-03-03 | Adidas Ag | Multimodal method and system for transmitting information about a subject |
US8519867B2 (en) * | 2010-12-23 | 2013-08-27 | General Electric Company | Method and system for reducing transmitter power consumption while avoiding delay of displayed information |
US10368796B2 (en) | 2011-07-22 | 2019-08-06 | Tc13-Pressure Applications Llc | Systems and methods for monitoring and providing therapeutic support for a user |
US9277829B2 (en) * | 2011-07-22 | 2016-03-08 | TC13—Pressure Applications LLC | Systems and methods for monitoring and providing therapeutic support for a user |
CA2864817A1 (en) | 2012-02-17 | 2013-08-22 | University of Virginia Patent Foundation, d/b/a University of Virginia Licensing & Ventures Group | Energy harvesting and control for sensor node |
US20140081155A1 (en) * | 2012-09-14 | 2014-03-20 | Scott R. Coggins | Methods And Apparatus for Wireless Electrode Having Power Conservation |
US10254785B2 (en) | 2014-06-30 | 2019-04-09 | Cerora, Inc. | System and methods for the synchronization of a non-real time operating system PC to a remote real-time data collecting microcontroller |
US10398369B2 (en) | 2014-08-08 | 2019-09-03 | Medtronic Xomed, Inc. | Wireless stimulation probe device for wireless nerve integrity monitoring systems |
US10039915B2 (en) | 2015-04-03 | 2018-08-07 | Medtronic Xomed, Inc. | System and method for omni-directional bipolar stimulation of nerve tissue of a patient via a surgical tool |
US10339273B2 (en) | 2015-11-18 | 2019-07-02 | Warsaw Orthopedic, Inc. | Systems and methods for pre-operative procedure determination and outcome predicting |
US10445466B2 (en) | 2015-11-18 | 2019-10-15 | Warsaw Orthopedic, Inc. | Systems and methods for post-operative outcome monitoring |
US11020035B2 (en) | 2016-02-01 | 2021-06-01 | Epitel, Inc. | Self-contained EEG recording system |
US10849517B2 (en) | 2016-09-19 | 2020-12-01 | Medtronic Xomed, Inc. | Remote control module for instruments |
WO2018213495A1 (en) * | 2017-05-16 | 2018-11-22 | Beth Israel Deaconess Medical Center, Inc. | Needle impedance electromyography and electrical impedance imaging for enhanced muscle diagnostics |
US11399762B1 (en) | 2021-08-05 | 2022-08-02 | Starcat LLC | Modular electroencephalograph (EEG) system |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5168874A (en) * | 1989-02-15 | 1992-12-08 | Jacob Segalowitz | Wireless electrode structure for use in patient monitoring system |
US5222503A (en) * | 1991-04-24 | 1993-06-29 | Beth Israel Hospital Association | Ambulatory electroencephalography system |
US5233999A (en) * | 1990-12-28 | 1993-08-10 | Alberto Dellacorna | Electromyograph with data transmission comprising no metallic conductors |
US5417222A (en) * | 1994-01-21 | 1995-05-23 | Hewlett-Packard Company | Patient monitoring system |
US5579781A (en) * | 1994-10-13 | 1996-12-03 | Cooke; Thomas H. | Wireless transmitter for needle electrodes as used in electromyography |
US5755230A (en) * | 1995-09-18 | 1998-05-26 | Cleveland Medical Devices Inc. | Wireless EEG system for effective auditory evoked response |
US5936710A (en) * | 1996-01-05 | 1999-08-10 | Canon Kabushiki Kaisha | Scanning type exposure apparatus, position control apparatus, and method therefor |
US5957860A (en) * | 1995-08-04 | 1999-09-28 | Rodiera Olive; Jose J | Method and apparatus for monitoring and/or controlling the neuromuscular blocking, specially the blocking produced by muscular relaxing pharmaceuticals during anaesthesia |
US6026321A (en) * | 1997-04-02 | 2000-02-15 | Suzuki Motor Corporation | Apparatus and system for measuring electrical potential variations in human body |
US6230049B1 (en) * | 1999-08-13 | 2001-05-08 | Neuro Pace, Inc. | Integrated system for EEG monitoring and electrical stimulation with a multiplicity of electrodes |
US6408045B1 (en) * | 1997-11-11 | 2002-06-18 | Canon Kabushiki Kaisha | Stage system and exposure apparatus with the same |
US20020115914A1 (en) * | 2001-02-14 | 2002-08-22 | Tomas Russ | Patient monitoring area network |
US20020140921A1 (en) * | 2001-02-19 | 2002-10-03 | Canon Kabushiki Kaisha | Active anti-vibration apparatus and exposure apparatus and device manufacturing method using the same |
US6470893B1 (en) * | 2000-05-15 | 2002-10-29 | Peter V. Boesen | Wireless biopotential sensing device and method with capability of short-range radio frequency transmission and reception |
US6496705B1 (en) * | 2000-04-18 | 2002-12-17 | Motorola Inc. | Programmable wireless electrode system for medical monitoring |
US20020198604A1 (en) * | 1997-02-26 | 2002-12-26 | Schulman Joseph H. | Method and apparatus for coupling an implantable stimulator/sensor to a prosthetic device |
US6577893B1 (en) * | 1993-09-04 | 2003-06-10 | Motorola, Inc. | Wireless medical diagnosis and monitoring equipment |
US6643541B2 (en) * | 2001-12-07 | 2003-11-04 | Motorola, Inc | Wireless electromyography sensor and system |
US20030229274A1 (en) * | 2002-06-07 | 2003-12-11 | Barnes-Jewish Hospital | Electromyograph having telemetry |
US20040068195A1 (en) * | 2002-10-02 | 2004-04-08 | Louis Massicotte | Method and apparatus for wearable digital wireless ECG monitoring |
US20040199056A1 (en) * | 2003-04-03 | 2004-10-07 | International Business Machines Corporation | Body monitoring using local area wireless interfaces |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4886064A (en) * | 1987-11-25 | 1989-12-12 | Siemens Aktiengesellschaft | Body activity controlled heart pacer |
DE59007743D1 (en) | 1989-01-27 | 1995-01-05 | Medese Ag | BIOTELEMETRY METHOD FOR TRANSMITTING BIOELECTRICAL POTENTIAL DIFFERENCES, AND DEVICE FOR TRANSMITTING ECG SIGNALS. |
US5307818A (en) | 1989-02-15 | 1994-05-03 | Jacob Segalowitz | Wireless electrocardiographic and monitoring system and wireless electrode assemblies for same |
US5511553A (en) * | 1989-02-15 | 1996-04-30 | Segalowitz; Jacob | Device-system and method for monitoring multiple physiological parameters (MMPP) continuously and simultaneously |
EP0436766A1 (en) | 1990-01-12 | 1991-07-17 | Siemens Aktiengesellschaft | Medical diagnostic system |
JPH05245215A (en) * | 1992-03-03 | 1993-09-24 | Terumo Corp | Heart pace maker |
DK0617914T3 (en) | 1993-03-31 | 1999-06-21 | Siemens Medical Systems Inc | Device and method for delivering dual output signals in a telemetry transmitter |
US5838223A (en) | 1993-07-12 | 1998-11-17 | Hill-Rom, Inc. | Patient/nurse call system |
US5394882A (en) * | 1993-07-21 | 1995-03-07 | Respironics, Inc. | Physiological monitoring system |
US5544661A (en) * | 1994-01-13 | 1996-08-13 | Charles L. Davis | Real time ambulatory patient monitor |
US5458124A (en) | 1994-02-08 | 1995-10-17 | Stanko; Bruce E. | Electrocardiographic signal monitoring system |
US5867688A (en) | 1994-02-14 | 1999-02-02 | Reliable Transaction Processing, Inc. | Data acquisition and retrieval system with wireless handheld user interface |
US5971931A (en) | 1994-03-29 | 1999-10-26 | Raff; Gilbert Lewis | Biologic micromonitoring methods and systems |
US5664270A (en) | 1994-07-19 | 1997-09-09 | Kinetic Concepts, Inc. | Patient interface system |
US5596267A (en) | 1994-12-22 | 1997-01-21 | Atlantic Richfield Company | Apparatus and method for measuring potentials through pavements for buried pipeline cathodic protection systems |
US20010034475A1 (en) | 1995-11-13 | 2001-10-25 | Flach Terry E. | Wireless lan system with cellular architecture |
US5944659A (en) | 1995-11-13 | 1999-08-31 | Vitalcom Inc. | Architecture for TDMA medical telemetry system |
US6686910B2 (en) | 1996-04-22 | 2004-02-03 | O'donnell, Jr. Francis E. | Combined writing instrument and digital documentor apparatus and method of use |
US5924074A (en) | 1996-09-27 | 1999-07-13 | Azron Incorporated | Electronic medical records system |
US5964701A (en) | 1996-10-24 | 1999-10-12 | Massachusetts Institute Of Technology | Patient monitoring finger ring sensor |
US5959287A (en) | 1997-04-23 | 1999-09-28 | Lxe Inc. | Apparatus and method for supporting a cradle |
US5987335A (en) | 1997-09-24 | 1999-11-16 | Lucent Technologies Inc. | Communication system comprising lightning protection |
DE69838473T2 (en) * | 1997-12-25 | 2008-01-17 | Nihon Kohden Corp. | Device for transmitting biological signals |
US5904708A (en) * | 1998-03-19 | 1999-05-18 | Medtronic, Inc. | System and method for deriving relative physiologic signals |
US6949816B2 (en) * | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
US6093146A (en) | 1998-06-05 | 2000-07-25 | Matsushita Electric Works, Ltd. | Physiological monitoring |
WO2000040146A1 (en) * | 1999-01-06 | 2000-07-13 | Ball Semiconductor, Inc. | Wireless ekg |
US20020035484A1 (en) | 1999-04-12 | 2002-03-21 | Glenn F Frankenberger | System and method of generating a medication prescription |
US6445955B1 (en) * | 1999-07-08 | 2002-09-03 | Stephen A. Michelson | Miniature wireless transcutaneous electrical neuro or muscular-stimulation unit |
US6289228B1 (en) * | 1999-07-20 | 2001-09-11 | Motorola, Inc. | Method and apparatus for reducing power consumption of a communication device |
US6675219B1 (en) | 1999-11-01 | 2004-01-06 | Nokia Corporation | Technique for improving throughput of a gateway interface |
US7060031B2 (en) * | 1999-12-17 | 2006-06-13 | Medtronic, Inc. | Method and apparatus for remotely programming implantable medical devices |
US6471645B1 (en) * | 1999-12-30 | 2002-10-29 | Medtronic, Inc. | Communications system for an implantable device and a drug dispenser |
US6438413B1 (en) | 2000-01-31 | 2002-08-20 | Integrated Biosensing Technologies | Biopotential sensor electrode system |
US6434421B1 (en) | 2000-01-31 | 2002-08-13 | Integrated Biosensing Technologies | Biopotential sensor electrode |
US6434420B1 (en) | 2000-01-31 | 2002-08-13 | Integrated Biosensing Technologies | Biopotential electrode sensory component |
US6443890B1 (en) | 2000-03-01 | 2002-09-03 | I-Medik, Inc. | Wireless internet bio-telemetry monitoring system |
US6441747B1 (en) * | 2000-04-18 | 2002-08-27 | Motorola, Inc. | Wireless system protocol for telemetry monitoring |
US6988989B2 (en) | 2000-05-19 | 2006-01-24 | Welch Allyn Protocol, Inc. | Patient monitoring system |
US6577901B2 (en) | 2000-06-23 | 2003-06-10 | Medtronic, Inc. | Network compatible RF wireless link for medical device data management |
FR2811163B1 (en) | 2000-06-30 | 2002-10-04 | Centre Nat Rech Scient | NONOELECTROMECHANICAL FILTER |
MXPA03000499A (en) | 2000-07-18 | 2003-06-24 | Motorola Inc | Wireless electrocardiograph system and method. |
US6690959B2 (en) | 2000-09-01 | 2004-02-10 | Medtronic, Inc. | Skin-mounted electrodes with nano spikes |
US6738671B2 (en) * | 2000-10-26 | 2004-05-18 | Medtronic, Inc. | Externally worn transceiver for use with an implantable medical device |
EP1347705B1 (en) | 2000-12-21 | 2005-12-07 | Insulet Corporation | Medical apparatus remote control |
US6445299B1 (en) | 2001-01-29 | 2002-09-03 | Antonio Rojas, Jr. | Retrofit for patient call system and method therefor |
US6753783B2 (en) | 2001-03-30 | 2004-06-22 | Augmentech, Inc. | Patient positioning monitoring apparatus and method of use thereof |
JP2002312473A (en) | 2001-04-11 | 2002-10-25 | Matsushita Electric Ind Co Ltd | Health examination system |
US6662052B1 (en) * | 2001-04-19 | 2003-12-09 | Nac Technologies Inc. | Method and system for neuromodulation therapy using external stimulator with wireless communication capabilites |
US6654631B1 (en) | 2001-07-12 | 2003-11-25 | Anil Sahai | Method and apparatus for a hand-held computer EKG device |
US7933642B2 (en) | 2001-07-17 | 2011-04-26 | Rud Istvan | Wireless ECG system |
JP3084145U (en) | 2001-08-17 | 2002-03-08 | 株式会社眼科器械のマキノ | Ophthalmic care system |
CN1311781C (en) | 2001-08-20 | 2007-04-25 | 因弗内斯医疗有限公司 | Wireless diabetes management devices and methods for using the same |
US20030045787A1 (en) | 2001-09-05 | 2003-03-06 | Schulze Arthur E. | Apparatus and method for recording an electrocardiogram using non-obtrusive sensors |
US6712754B2 (en) | 2002-02-26 | 2004-03-30 | Otologics Llc | Method and system for positioning implanted hearing aid actuators |
US20030163350A1 (en) | 2002-02-26 | 2003-08-28 | Robert Rudowski | Automated system facilitating interactions between physicians and medical services or equipment providers |
AUPS101502A0 (en) * | 2002-03-11 | 2002-04-11 | Neopraxis Pty Ltd | Wireless fes system |
JP3803085B2 (en) | 2002-08-08 | 2006-08-02 | 株式会社日立製作所 | Wireless IC tag |
US20040049240A1 (en) | 2002-09-06 | 2004-03-11 | Martin Gerber | Electrical and/or magnetic stimulation therapy for the treatment of prostatitis and prostatodynia |
US7194298B2 (en) | 2002-10-02 | 2007-03-20 | Medicale Intelligence Inc. | Method and apparatus for trend detection in an electrocardiogram monitoring signal |
US7027871B2 (en) * | 2002-10-31 | 2006-04-11 | Medtronic, Inc. | Aggregation of data from external data sources within an implantable medical device |
US20050101843A1 (en) * | 2003-11-06 | 2005-05-12 | Welch Allyn, Inc. | Wireless disposable physiological sensor |
-
2005
- 2005-05-17 US US11/130,221 patent/US20050261559A1/en not_active Abandoned
-
2008
- 2008-12-10 US US12/332,105 patent/US8805527B2/en active Active
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5168874A (en) * | 1989-02-15 | 1992-12-08 | Jacob Segalowitz | Wireless electrode structure for use in patient monitoring system |
US5233999A (en) * | 1990-12-28 | 1993-08-10 | Alberto Dellacorna | Electromyograph with data transmission comprising no metallic conductors |
US5222503A (en) * | 1991-04-24 | 1993-06-29 | Beth Israel Hospital Association | Ambulatory electroencephalography system |
US6577893B1 (en) * | 1993-09-04 | 2003-06-10 | Motorola, Inc. | Wireless medical diagnosis and monitoring equipment |
US5417222A (en) * | 1994-01-21 | 1995-05-23 | Hewlett-Packard Company | Patient monitoring system |
US5579781A (en) * | 1994-10-13 | 1996-12-03 | Cooke; Thomas H. | Wireless transmitter for needle electrodes as used in electromyography |
US5957860A (en) * | 1995-08-04 | 1999-09-28 | Rodiera Olive; Jose J | Method and apparatus for monitoring and/or controlling the neuromuscular blocking, specially the blocking produced by muscular relaxing pharmaceuticals during anaesthesia |
US5755230A (en) * | 1995-09-18 | 1998-05-26 | Cleveland Medical Devices Inc. | Wireless EEG system for effective auditory evoked response |
US5936710A (en) * | 1996-01-05 | 1999-08-10 | Canon Kabushiki Kaisha | Scanning type exposure apparatus, position control apparatus, and method therefor |
US6160612A (en) * | 1996-01-05 | 2000-12-12 | Canon Kabushiki Kaisha | Scanning type exposure apparatus, position control apparatus, and method therefor |
US20020198604A1 (en) * | 1997-02-26 | 2002-12-26 | Schulman Joseph H. | Method and apparatus for coupling an implantable stimulator/sensor to a prosthetic device |
US6026321A (en) * | 1997-04-02 | 2000-02-15 | Suzuki Motor Corporation | Apparatus and system for measuring electrical potential variations in human body |
US6408045B1 (en) * | 1997-11-11 | 2002-06-18 | Canon Kabushiki Kaisha | Stage system and exposure apparatus with the same |
US6230049B1 (en) * | 1999-08-13 | 2001-05-08 | Neuro Pace, Inc. | Integrated system for EEG monitoring and electrical stimulation with a multiplicity of electrodes |
US6496705B1 (en) * | 2000-04-18 | 2002-12-17 | Motorola Inc. | Programmable wireless electrode system for medical monitoring |
US6470893B1 (en) * | 2000-05-15 | 2002-10-29 | Peter V. Boesen | Wireless biopotential sensing device and method with capability of short-range radio frequency transmission and reception |
US20020115914A1 (en) * | 2001-02-14 | 2002-08-22 | Tomas Russ | Patient monitoring area network |
US20020140921A1 (en) * | 2001-02-19 | 2002-10-03 | Canon Kabushiki Kaisha | Active anti-vibration apparatus and exposure apparatus and device manufacturing method using the same |
US6643541B2 (en) * | 2001-12-07 | 2003-11-04 | Motorola, Inc | Wireless electromyography sensor and system |
US20030229274A1 (en) * | 2002-06-07 | 2003-12-11 | Barnes-Jewish Hospital | Electromyograph having telemetry |
US20040068195A1 (en) * | 2002-10-02 | 2004-04-08 | Louis Massicotte | Method and apparatus for wearable digital wireless ECG monitoring |
US20040199056A1 (en) * | 2003-04-03 | 2004-10-07 | International Business Machines Corporation | Body monitoring using local area wireless interfaces |
Cited By (214)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060258930A1 (en) * | 2004-05-18 | 2006-11-16 | Jianping Wu | Device for use in sleep stage determination using frontal electrodes |
US20050268916A1 (en) * | 2004-05-18 | 2005-12-08 | Mumford John R | Mask assembly with integrated sensors |
US7575005B2 (en) | 2004-05-18 | 2009-08-18 | Excel-Tech Ltd. | Mask assembly with integrated sensors |
US20070208269A1 (en) * | 2004-05-18 | 2007-09-06 | Mumford John R | Mask assembly, system and method for determining the occurrence of respiratory events using frontal electrode array |
US20060071934A1 (en) * | 2004-10-01 | 2006-04-06 | Sony Corporation | System and method for tracking facial muscle and eye motion for computer graphics animation |
US7554549B2 (en) * | 2004-10-01 | 2009-06-30 | Sony Corporation | System and method for tracking facial muscle and eye motion for computer graphics animation |
US20170049338A1 (en) * | 2005-04-14 | 2017-02-23 | Hidalgo Limited | Apparatus and system for monitoring |
US20220015647A1 (en) * | 2005-04-14 | 2022-01-20 | Hidalgo Limited | Apparatus and system for monitoring |
US20130237772A1 (en) * | 2005-04-14 | 2013-09-12 | Hidalgo Limited | Apparatus and system for monitoring |
US20100063365A1 (en) * | 2005-04-14 | 2010-03-11 | Hidalgo Limited | Apparatus and System for Monitoring |
US20150313476A1 (en) * | 2005-04-14 | 2015-11-05 | Hildalgo Limited | Apparatus and system for monitoring |
US9597010B2 (en) | 2005-04-28 | 2017-03-21 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US9161707B2 (en) | 2005-04-28 | 2015-10-20 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US9681842B2 (en) | 2005-04-28 | 2017-06-20 | Proteus Digital Health, Inc. | Pharma-informatics system |
US9439582B2 (en) | 2005-04-28 | 2016-09-13 | Proteus Digital Health, Inc. | Communication system with remote activation |
US8816847B2 (en) | 2005-04-28 | 2014-08-26 | Proteus Digital Health, Inc. | Communication system with partial power source |
US9962107B2 (en) | 2005-04-28 | 2018-05-08 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US10517507B2 (en) | 2005-04-28 | 2019-12-31 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US8847766B2 (en) | 2005-04-28 | 2014-09-30 | Proteus Digital Health, Inc. | Pharma-informatics system |
US9649066B2 (en) | 2005-04-28 | 2017-05-16 | Proteus Digital Health, Inc. | Communication system with partial power source |
US8674825B2 (en) | 2005-04-28 | 2014-03-18 | Proteus Digital Health, Inc. | Pharma-informatics system |
US11476952B2 (en) | 2005-04-28 | 2022-10-18 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
US8730031B2 (en) | 2005-04-28 | 2014-05-20 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US10542909B2 (en) | 2005-04-28 | 2020-01-28 | Proteus Digital Health, Inc. | Communication system with partial power source |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
US9119554B2 (en) | 2005-04-28 | 2015-09-01 | Proteus Digital Health, Inc. | Pharma-informatics system |
US7978064B2 (en) | 2005-04-28 | 2011-07-12 | Proteus Biomedical, Inc. | Communication system with partial power source |
US10610128B2 (en) | 2005-04-28 | 2020-04-07 | Proteus Digital Health, Inc. | Pharma-informatics system |
US11006691B2 (en) | 2005-06-27 | 2021-05-18 | Nike, Inc. | Systems for activating and/or authenticating electronic devices for operation with footwear and other uses |
US9913509B2 (en) | 2005-06-27 | 2018-03-13 | Nike, Inc. | Systems for activating and/or authenticating electronic devices for operation with footwear and other uses |
US20070027388A1 (en) * | 2005-08-01 | 2007-02-01 | Chang-An Chou | Patch-type physiological monitoring apparatus, system and network |
US20070033069A1 (en) * | 2005-08-08 | 2007-02-08 | Rajendra Rao | Fitness network system |
GB2430038A (en) * | 2005-08-12 | 2007-03-14 | Draeger Medical Ag | Housing System For Medical Sensors |
GB2430038B (en) * | 2005-08-12 | 2008-06-18 | Draeger Medical Ag | Housing system for medical sensors |
US8547248B2 (en) | 2005-09-01 | 2013-10-01 | Proteus Digital Health, Inc. | Implantable zero-wire communications system |
US10893037B2 (en) | 2005-12-14 | 2021-01-12 | Welch Allyn, Inc. | Medical device wireless adapter |
US20070135866A1 (en) * | 2005-12-14 | 2007-06-14 | Welch Allyn Inc. | Medical device wireless adapter |
US8224025B2 (en) | 2005-12-23 | 2012-07-17 | Sony Corporation | Group tracking in motion capture |
US20070146370A1 (en) * | 2005-12-23 | 2007-06-28 | Demian Gordon | Group tracking in motion capture |
WO2007091193A3 (en) * | 2006-02-09 | 2007-12-13 | Koninkl Philips Electronics Nv | Device for monitoring the status of a patient and treatment based thereupon |
US20090093691A1 (en) * | 2006-02-09 | 2009-04-09 | Konklijke Philips Electronics N.V. | Device for monitoring the status of a patient and treatment based thereupon |
US8870791B2 (en) | 2006-03-23 | 2014-10-28 | Michael E. Sabatino | Apparatus for acquiring, processing and transmitting physiological sounds |
US8920343B2 (en) | 2006-03-23 | 2014-12-30 | Michael Edward Sabatino | Apparatus for acquiring and processing of physiological auditory signals |
US11357471B2 (en) | 2006-03-23 | 2022-06-14 | Michael E. Sabatino | Acquiring and processing acoustic energy emitted by at least one organ in a biological system |
US11207563B2 (en) | 2006-04-20 | 2021-12-28 | Nike, Inc. | Systems for activating electronic devices for operation with apparel |
US10300335B2 (en) | 2006-04-20 | 2019-05-28 | Nike, Inc. | Systems for activating electronic devices for operation with athletic equipment |
US8188868B2 (en) | 2006-04-20 | 2012-05-29 | Nike, Inc. | Systems for activating and/or authenticating electronic devices for operation with apparel |
US20080125288A1 (en) * | 2006-04-20 | 2008-05-29 | Nike, Inc. | Systems for activating and/or authenticating electronic devices for operation with apparel and equipment |
US9259613B2 (en) | 2006-04-20 | 2016-02-16 | Nike, Inc. | Systems for activating electronic devices for operation with athletic equipment |
JP2009534546A (en) * | 2006-04-20 | 2009-09-24 | ナイキ インコーポレーティッド | System for activation and / or authentication of electronic devices for the operation of clothing and utensils |
US9649532B2 (en) | 2006-04-20 | 2017-05-16 | Nike, Inc. | Golf club including an electronic module |
US9555285B2 (en) | 2006-04-20 | 2017-01-31 | Nike, Inc. | Systems for activating electronic devices for operation with athletic equipment |
US9844698B2 (en) | 2006-04-20 | 2017-12-19 | Nike, Inc. | Systems for activating electronic devices for operation with athletic equipment |
US8350708B2 (en) | 2006-04-20 | 2013-01-08 | Nike, Inc. | Systems for activating and/or authenticating electronic devices for operation with athletic equipment |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US11928614B2 (en) | 2006-05-02 | 2024-03-12 | Otsuka Pharmaceutical Co., Ltd. | Patient customized therapeutic regimens |
US8956287B2 (en) | 2006-05-02 | 2015-02-17 | Proteus Digital Health, Inc. | Patient customized therapeutic regimens |
US8968195B2 (en) | 2006-05-12 | 2015-03-03 | Bao Tran | Health monitoring appliance |
US9060683B2 (en) | 2006-05-12 | 2015-06-23 | Bao Tran | Mobile wireless appliance |
US8747313B2 (en) * | 2006-05-12 | 2014-06-10 | Bao Tran | Health monitoring appliance |
US9820657B2 (en) | 2006-05-12 | 2017-11-21 | Koninklijke Philips N.V. | Mobile wireless appliance |
US9215980B2 (en) | 2006-05-12 | 2015-12-22 | Empire Ip Llc | Health monitoring appliance |
US9028405B2 (en) | 2006-05-16 | 2015-05-12 | Bao Tran | Personal monitoring system |
US10610111B1 (en) | 2006-06-30 | 2020-04-07 | Bao Tran | Smart watch |
US10729336B1 (en) | 2006-06-30 | 2020-08-04 | Bao Tran | Smart watch |
WO2008012398A1 (en) * | 2006-07-25 | 2008-01-31 | Mediracer Ltd. | Method and equipment for controlling the measurement of nerve response wirelessly |
US8054140B2 (en) | 2006-10-17 | 2011-11-08 | Proteus Biomedical, Inc. | Low voltage oscillator for medical devices |
US11357730B2 (en) | 2006-10-25 | 2022-06-14 | Otsuka Pharmaceutical Co., Ltd. | Controlled activation ingestible identifier |
US8945005B2 (en) | 2006-10-25 | 2015-02-03 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
US10238604B2 (en) | 2006-10-25 | 2019-03-26 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
US8718193B2 (en) | 2006-11-20 | 2014-05-06 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
US9444503B2 (en) | 2006-11-20 | 2016-09-13 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
US9083589B2 (en) | 2006-11-20 | 2015-07-14 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
WO2008076372A2 (en) * | 2006-12-15 | 2008-06-26 | Neurometrix, Inc. | Neurological diagnostic and therapeutic system utilizing function-specific modules |
WO2008076372A3 (en) * | 2006-12-15 | 2008-10-23 | Neurometrix Inc | Neurological diagnostic and therapeutic system utilizing function-specific modules |
US20080281378A1 (en) * | 2006-12-15 | 2008-11-13 | Michael Williams | Neurological diagnostic and therapeutic system utilizing function-specific modules |
US20080154111A1 (en) * | 2006-12-22 | 2008-06-26 | Jianping Wu | Method, system and device for sleep stage determination using frontal electrodes |
US8244340B2 (en) | 2006-12-22 | 2012-08-14 | Natus Medical Incorporated | Method, system and device for sleep stage determination using frontal electrodes |
US8858432B2 (en) | 2007-02-01 | 2014-10-14 | Proteus Digital Health, Inc. | Ingestible event marker systems |
US10441194B2 (en) | 2007-02-01 | 2019-10-15 | Proteus Digital Heal Th, Inc. | Ingestible event marker systems |
US11464423B2 (en) | 2007-02-14 | 2022-10-11 | Otsuka Pharmaceutical Co., Ltd. | In-body power source having high surface area electrode |
US8956288B2 (en) | 2007-02-14 | 2015-02-17 | Proteus Digital Health, Inc. | In-body power source having high surface area electrode |
US9270025B2 (en) | 2007-03-09 | 2016-02-23 | Proteus Digital Health, Inc. | In-body device having deployable antenna |
US8932221B2 (en) | 2007-03-09 | 2015-01-13 | Proteus Digital Health, Inc. | In-body device having a multi-directional transmitter |
US9042978B2 (en) | 2007-05-11 | 2015-05-26 | Neurometrix, Inc. | Method and apparatus for quantitative nerve localization |
US20090299214A1 (en) * | 2007-05-11 | 2009-12-03 | Changwang Wu | Method and apparatus for quantitative nerve localization |
US10517506B2 (en) | 2007-05-24 | 2019-12-31 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
US8540632B2 (en) | 2007-05-24 | 2013-09-24 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
US20080306348A1 (en) * | 2007-06-06 | 2008-12-11 | National Yang-Ming University | Miniature wireless apparatus for recording physiological signals of humans and use thereof |
US20090024044A1 (en) * | 2007-07-17 | 2009-01-22 | The General Electric Company | Data recording for patient status analysis |
GB2454960B (en) * | 2007-07-17 | 2012-03-21 | Gen Electric | Data recording for patient status analysis |
GB2454960A (en) * | 2007-07-17 | 2009-05-27 | Gen Electric | Data recording for patient status analysis |
US8961412B2 (en) | 2007-09-25 | 2015-02-24 | Proteus Digital Health, Inc. | In-body device with virtual dipole signal amplification |
US9433371B2 (en) | 2007-09-25 | 2016-09-06 | Proteus Digital Health, Inc. | In-body device with virtual dipole signal amplification |
US20090085768A1 (en) * | 2007-10-02 | 2009-04-02 | Medtronic Minimed, Inc. | Glucose sensor transceiver |
US9060708B2 (en) | 2008-03-05 | 2015-06-23 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US8810409B2 (en) | 2008-03-05 | 2014-08-19 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US9258035B2 (en) | 2008-03-05 | 2016-02-09 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US8542123B2 (en) | 2008-03-05 | 2013-09-24 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US8258962B2 (en) | 2008-03-05 | 2012-09-04 | Proteus Biomedical, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US8579794B2 (en) | 2008-05-02 | 2013-11-12 | Dymedix Corporation | Agitator to stimulate the central nervous system |
US10682071B2 (en) | 2008-07-08 | 2020-06-16 | Proteus Digital Health, Inc. | State characterization based on multi-variate data fusion techniques |
US9603550B2 (en) | 2008-07-08 | 2017-03-28 | Proteus Digital Health, Inc. | State characterization based on multi-variate data fusion techniques |
US11217342B2 (en) | 2008-07-08 | 2022-01-04 | Otsuka Pharmaceutical Co., Ltd. | Ingestible event marker data framework |
US9415010B2 (en) | 2008-08-13 | 2016-08-16 | Proteus Digital Health, Inc. | Ingestible circuitry |
US8540633B2 (en) | 2008-08-13 | 2013-09-24 | Proteus Digital Health, Inc. | Identifier circuits for generating unique identifiable indicators and techniques for producing same |
US8721540B2 (en) | 2008-08-13 | 2014-05-13 | Proteus Digital Health, Inc. | Ingestible circuitry |
US8834346B2 (en) | 2008-08-22 | 2014-09-16 | Dymedix Corporation | Stimulus sequencer for a closed loop neuromodulator |
US8834347B2 (en) | 2008-08-22 | 2014-09-16 | Dymedix Corporation | Anti-habituating sleep therapy for a closed loop neuromodulator |
US8036748B2 (en) | 2008-11-13 | 2011-10-11 | Proteus Biomedical, Inc. | Ingestible therapy activator system and method |
US8055334B2 (en) | 2008-12-11 | 2011-11-08 | Proteus Biomedical, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
US8583227B2 (en) | 2008-12-11 | 2013-11-12 | Proteus Digital Health, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
US8114021B2 (en) | 2008-12-15 | 2012-02-14 | Proteus Biomedical, Inc. | Body-associated receiver and method |
US9149577B2 (en) | 2008-12-15 | 2015-10-06 | Proteus Digital Health, Inc. | Body-associated receiver and method |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
US8545436B2 (en) | 2008-12-15 | 2013-10-01 | Proteus Digital Health, Inc. | Body-associated receiver and method |
US8597186B2 (en) | 2009-01-06 | 2013-12-03 | Proteus Digital Health, Inc. | Pharmaceutical dosages delivery system |
US9883819B2 (en) | 2009-01-06 | 2018-02-06 | Proteus Digital Health, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
US9492105B1 (en) * | 2009-02-13 | 2016-11-15 | Cleveland Medical Devices Inc. | Device for sleep diagnosis |
US9119918B2 (en) | 2009-03-25 | 2015-09-01 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
US8540664B2 (en) | 2009-03-25 | 2013-09-24 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
US8545402B2 (en) | 2009-04-28 | 2013-10-01 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US9320455B2 (en) | 2009-04-28 | 2016-04-26 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US10588544B2 (en) | 2009-04-28 | 2020-03-17 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US9149423B2 (en) | 2009-05-12 | 2015-10-06 | Proteus Digital Health, Inc. | Ingestible event markers comprising an ingestible component |
US20110009729A1 (en) * | 2009-07-08 | 2011-01-13 | Electronics And Telecommunications Research Institute | Apparatus for measuring physiological signals |
US8558563B2 (en) | 2009-08-21 | 2013-10-15 | Proteus Digital Health, Inc. | Apparatus and method for measuring biochemical parameters |
US8868453B2 (en) | 2009-11-04 | 2014-10-21 | Proteus Digital Health, Inc. | System for supply chain management |
US10305544B2 (en) | 2009-11-04 | 2019-05-28 | Proteus Digital Health, Inc. | System for supply chain management |
US9941931B2 (en) | 2009-11-04 | 2018-04-10 | Proteus Digital Health, Inc. | System for supply chain management |
US8784308B2 (en) | 2009-12-02 | 2014-07-22 | Proteus Digital Health, Inc. | Integrated ingestible event marker system with pharmaceutical product |
US10376218B2 (en) | 2010-02-01 | 2019-08-13 | Proteus Digital Health, Inc. | Data gathering system |
US9014779B2 (en) | 2010-02-01 | 2015-04-21 | Proteus Digital Health, Inc. | Data gathering system |
US10207093B2 (en) | 2010-04-07 | 2019-02-19 | Proteus Digital Health, Inc. | Miniature ingestible device |
US11173290B2 (en) | 2010-04-07 | 2021-11-16 | Otsuka Pharmaceutical Co., Ltd. | Miniature ingestible device |
US9597487B2 (en) | 2010-04-07 | 2017-03-21 | Proteus Digital Health, Inc. | Miniature ingestible device |
US10529044B2 (en) | 2010-05-19 | 2020-01-07 | Proteus Digital Health, Inc. | Tracking and delivery confirmation of pharmaceutical products |
US9107806B2 (en) | 2010-11-22 | 2015-08-18 | Proteus Digital Health, Inc. | Ingestible device with pharmaceutical product |
US11504511B2 (en) | 2010-11-22 | 2022-11-22 | Otsuka Pharmaceutical Co., Ltd. | Ingestible device with pharmaceutical product |
US9439599B2 (en) | 2011-03-11 | 2016-09-13 | Proteus Digital Health, Inc. | Wearable personal body associated device with various physical configurations |
US11229378B2 (en) | 2011-07-11 | 2022-01-25 | Otsuka Pharmaceutical Co., Ltd. | Communication system with enhanced partial power source and method of manufacturing same |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US10223905B2 (en) | 2011-07-21 | 2019-03-05 | Proteus Digital Health, Inc. | Mobile device and system for detection and communication of information received from an ingestible device |
US20140203950A1 (en) * | 2011-07-21 | 2014-07-24 | Mark Zdeblick | Mobile Communication Device, System, and Method |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
US11642515B2 (en) | 2012-02-22 | 2023-05-09 | Medtronic, Inc. | Sensing and stimulation system |
WO2013134776A1 (en) * | 2012-03-09 | 2013-09-12 | Natus Medical Incorporated | Performance concentric electromyography needle |
US9271897B2 (en) | 2012-07-23 | 2016-03-01 | Proteus Digital Health, Inc. | Techniques for manufacturing ingestible event markers comprising an ingestible component |
US10413251B2 (en) * | 2012-10-07 | 2019-09-17 | Rhythm Diagnostic Systems, Inc. | Wearable cardiac monitor |
US20150094552A1 (en) * | 2012-10-07 | 2015-04-02 | Rhythm Diagnostics Systems, Inc. | Health monitoring systems and methods |
US10863947B2 (en) | 2012-10-07 | 2020-12-15 | Rds Sas | Health monitoring systems and methods |
US20140100432A1 (en) * | 2012-10-07 | 2014-04-10 | George Stefan Golda | Wearable Cardiac Monitor |
US10993671B2 (en) | 2012-10-07 | 2021-05-04 | Rds | Health monitoring systems and methods |
US11786182B2 (en) | 2012-10-07 | 2023-10-17 | Rds | Health monitoring systems and methods |
USD931467S1 (en) | 2012-10-07 | 2021-09-21 | Rds | Health monitoring apparatus |
US10244949B2 (en) | 2012-10-07 | 2019-04-02 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US10842391B2 (en) | 2012-10-07 | 2020-11-24 | Rds Sas | Health monitoring systems and methods |
US11185291B2 (en) | 2012-10-07 | 2021-11-30 | Rds | Health monitoring systems and methods |
US10080527B2 (en) * | 2012-10-07 | 2018-09-25 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US10980486B2 (en) | 2012-10-07 | 2021-04-20 | Rds | Health monitoring systems and methods |
US10610159B2 (en) | 2012-10-07 | 2020-04-07 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US20150148637A1 (en) * | 2012-10-07 | 2015-05-28 | Rhythm Diagnostics Systems, Inc. | Health monitoring systems and methods |
US9782132B2 (en) * | 2012-10-07 | 2017-10-10 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US10959678B2 (en) | 2012-10-07 | 2021-03-30 | Rds | Health monitoring systems and methods |
US9268909B2 (en) | 2012-10-18 | 2016-02-23 | Proteus Digital Health, Inc. | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
US9865176B2 (en) | 2012-12-07 | 2018-01-09 | Koninklijke Philips N.V. | Health monitoring system |
US11149123B2 (en) | 2013-01-29 | 2021-10-19 | Otsuka Pharmaceutical Co., Ltd. | Highly-swellable polymeric films and compositions comprising the same |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
USD850626S1 (en) | 2013-03-15 | 2019-06-04 | Rhythm Diagnostic Systems, Inc. | Health monitoring apparatuses |
US11741771B2 (en) | 2013-03-15 | 2023-08-29 | Otsuka Pharmaceutical Co., Ltd. | Personal authentication apparatus system and method |
US10175376B2 (en) | 2013-03-15 | 2019-01-08 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
US11026627B2 (en) | 2013-03-15 | 2021-06-08 | Cadwell Laboratories, Inc. | Surgical instruments for determining a location of a nerve during a procedure |
US11158149B2 (en) | 2013-03-15 | 2021-10-26 | Otsuka Pharmaceutical Co., Ltd. | Personal authentication apparatus system and method |
US10421658B2 (en) | 2013-08-30 | 2019-09-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
US9270503B2 (en) | 2013-09-20 | 2016-02-23 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US11102038B2 (en) | 2013-09-20 | 2021-08-24 | Otsuka Pharmaceutical Co., Ltd. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US10097388B2 (en) | 2013-09-20 | 2018-10-09 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US10498572B2 (en) | 2013-09-20 | 2019-12-03 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US9787511B2 (en) | 2013-09-20 | 2017-10-10 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US9577864B2 (en) | 2013-09-24 | 2017-02-21 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
JP2017502711A (en) * | 2013-11-07 | 2017-01-26 | セーフオプ サージカル インコーポレイテッド | System and method for detecting neural function |
EP3065636A4 (en) * | 2013-11-07 | 2017-12-06 | SafeOp Surgical, Inc. | Systems and methods for detecting nerve function |
US11083387B2 (en) | 2013-11-07 | 2021-08-10 | Safeop Surgical, Inc. | Systems and methods for detecting nerve function |
US10398161B2 (en) | 2014-01-21 | 2019-09-03 | Proteus Digital Heal Th, Inc. | Masticable ingestible product and communication system therefor |
US10265514B2 (en) | 2014-02-14 | 2019-04-23 | Medtronic, Inc. | Sensing and stimulation system |
US20150316594A1 (en) * | 2014-04-30 | 2015-11-05 | Jason Kania | Energy Monitoring and Analysis System |
US10564193B2 (en) * | 2014-04-30 | 2020-02-18 | Onbalance Technologies Inc. | Energy monitoring and analysis system |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
US10797758B2 (en) | 2016-07-22 | 2020-10-06 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
US10187121B2 (en) | 2016-07-22 | 2019-01-22 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
US11793419B2 (en) | 2016-10-26 | 2023-10-24 | Otsuka Pharmaceutical Co., Ltd. | Methods for manufacturing capsules with ingestible event markers |
US11529071B2 (en) | 2016-10-26 | 2022-12-20 | Otsuka Pharmaceutical Co., Ltd. | Methods for manufacturing capsules with ingestible event markers |
US11177610B2 (en) | 2017-01-23 | 2021-11-16 | Cadwell Laboratories, ino. | Neuromonitoring connection system |
WO2018216003A1 (en) * | 2017-05-25 | 2018-11-29 | Nanovation G.S. Ltd | Non-invasive device and method for sensing respiratory parameters |
US20190015048A1 (en) * | 2017-07-14 | 2019-01-17 | Welch Allyn, Inc. | Physical parameter measuring |
US10905376B2 (en) * | 2017-07-14 | 2021-02-02 | Welch Allyn, Inc. | Physical parameter measuring |
US11253182B2 (en) | 2018-05-04 | 2022-02-22 | Cadwell Laboratories, Inc. | Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation |
US11443649B2 (en) | 2018-06-29 | 2022-09-13 | Cadwell Laboratories, Inc. | Neurophysiological monitoring training simulator |
US11903700B2 (en) | 2019-08-28 | 2024-02-20 | Rds | Vital signs monitoring systems and methods |
US11786167B2 (en) | 2020-04-05 | 2023-10-17 | Epitel, Inc. | EEG recording and analysis |
US11779262B2 (en) * | 2020-04-05 | 2023-10-10 | Epitel, Inc. | EEG recording and analysis |
US11638551B2 (en) | 2020-04-05 | 2023-05-02 | Epitel, Inc. | EEG recording and analysis |
US20220338792A1 (en) * | 2020-04-05 | 2022-10-27 | Epitel, Inc. | Eeg recording and analysis |
WO2022163382A1 (en) * | 2021-01-27 | 2022-08-04 | 住友ベークライト株式会社 | Brain wave measuring electrode, brain wave measuring device, and brain wave measuring method |
JPWO2022163382A1 (en) * | 2021-01-27 | 2022-08-04 | ||
JP7294537B2 (en) | 2021-01-27 | 2023-06-20 | 住友ベークライト株式会社 | Electroencephalogram measurement electrode, electroencephalogram measurement device, and electroencephalogram measurement method |
US11857330B1 (en) | 2022-10-19 | 2024-01-02 | Epitel, Inc. | Systems and methods for electroencephalogram monitoring |
US11918368B1 (en) | 2022-10-19 | 2024-03-05 | Epitel, Inc. | Systems and methods for electroencephalogram monitoring |
Also Published As
Publication number | Publication date |
---|---|
US20090088608A1 (en) | 2009-04-02 |
US8805527B2 (en) | 2014-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8805527B2 (en) | Wireless physiological monitoring | |
JP7057671B2 (en) | Systems and Methods for Omnidirectional Bipolar Stimulation of Patient Nervous Tissue Using Bipolar Stimulation Probes | |
JP6749338B2 (en) | System and method for omnidirectional bipolar stimulation of a patient's nerve tissue using surgical instruments | |
US8112139B2 (en) | Skin screw electrode | |
AU2010315490B2 (en) | Biomedical electrode | |
US8027737B2 (en) | Lead extension with input capabilities | |
Thakor | Biopotentials and electrophysiology measurement | |
US20160157777A1 (en) | Headset for bio-signals acquisition | |
EP2327360B1 (en) | Method and apparatus for improving signal to noise ratio of ECG signals to facilitate cardiac beat detection | |
WO2006132958A2 (en) | Neurophysiological wireless bio-sensor | |
AU2008329623A1 (en) | Non-contact biopotential sensor | |
Srinivasa et al. | Dry electrodes for bio-potential measurement in wearable systems | |
CN111093469A (en) | System and method for inducing reflexes to monitor laryngeal nerves | |
US9504424B2 (en) | Skin screw electrodes | |
CA2507789C (en) | Wireless physiological monitoring system | |
US20230255560A1 (en) | Skin screw electrodes | |
EP3949850A1 (en) | Mobile electrocardiography recording device | |
Towe | Bioelectricity and its measurement | |
Carpi et al. | Non-invasive wet electrocochleography | |
WO2013077898A1 (en) | Improved skin screw electrodes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EXCEL-TECH LTD., CANADA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MUMFORD, JOHN ROBERT;KURTZ, RONALD LEON;REEL/FRAME:016728/0747 Effective date: 20050531 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |